{"meta":{"query_hash":"80a14a3e6f31","filters":{"venue":"Pharmacology Research & Perspectives"},"cohort_total":77,"direct_labels_cover":0,"predictions_cover":77,"exported":77,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/80a14a3e6f31","api":"https://metacan.xera.ac/api/v1/cohort?venue=Pharmacology+Research+%26+Perspectives"},"results":[{"id":"W1984312275","doi":"10.1002/prp2.46","title":"The in vivo efficacy and side effect pharmacology of <scp>GS</scp>‐5759, a novel bifunctional phosphodiesterase 4 inhibitor and long‐acting <i>β</i><sub>2</sub>‐adrenoceptor agonist in preclinical animal species","year":2014,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Calgary; Gilead Sciences","keywords":"Pharmacology; Phosphodiesterase; Agonist; In vivo; Medicine; Phosphodiesterase inhibitor; cGMP-specific phosphodiesterase type 5; Receptor; Chemistry; Endocrinology; Internal medicine; Biology; Enzyme; Biochemistry","score_opus":0.029495275734419398,"score_gpt":0.3578183425982132,"score_spread":0.3283230668637938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984312275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408895,0.0033418648,0.000054449643,0.0007961803,0.0004969923,0.0007249869,0.000019712837,0.00001553224,0.00046135348],"genre_scores_gemma":[0.9968709,0.0017980323,0.00003889101,0.000120704615,0.0007417494,0.00014762624,0.000013414325,0.000029028839,0.00023964961],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99682784,0.0010549219,0.00045552448,0.00074990623,0.0002896366,0.00062214833],"domain_scores_gemma":[0.9962805,0.0029771659,0.00015274076,0.00016594245,0.00024991523,0.00017376231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024290818,0.00026987525,0.00037677574,0.00024614076,0.00037664842,0.000060949067,0.00018825861,0.00023909687,0.000020483747],"category_scores_gemma":[0.0013464922,0.00022030069,0.000080531805,0.00031887164,0.0016518637,0.00003160862,0.00036367626,0.00068600854,0.0000031185937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002348009,0.0004307014,0.022340791,0.000056741974,0.00013196531,0.000007918727,0.000858664,0.000051862753,0.96980375,0.0000685182,0.0025184373,0.001382625],"study_design_scores_gemma":[0.005564452,0.0017102092,0.11099481,0.00003318798,0.000036605805,0.00003250369,0.0010118173,0.00041672634,0.87307686,0.000021762315,0.006977604,0.00012344678],"about_ca_topic_score_codex":0.000031596737,"about_ca_topic_score_gemma":0.0002676373,"teacher_disagreement_score":0.09672689,"about_ca_system_score_codex":0.000101451915,"about_ca_system_score_gemma":0.00015904133,"threshold_uncertainty_score":0.89836013},"labels":[],"label_agreement":null},{"id":"W1990422646","doi":"10.1002/prp2.76","title":"Analysis of FK506, timcodar (VX‐853) and FKBP51 and FKBP52 chaperones in control of glucocorticoid receptor activity and phosphorylation","year":2014,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; College of Graduate Studies, University of Toledo; National Institutes of Health; School of Medicine, New York University; York University; Stranahan Foundation; National Institute on Minority Health and Health Disparities; University of Toledo Foundation","keywords":"FKBP; Phosphorylation; Glucocorticoid receptor; Receptor; Endocrinology; Internal medicine; Glucocorticoid; Chemistry; Molecular biology; Biology; Cell biology; Medicine","score_opus":0.020045100937088774,"score_gpt":0.3588516178492234,"score_spread":0.33880651691213465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990422646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452937,0.0044526085,0.00019182092,0.00027626715,0.000028913406,0.00035373686,0.000042782365,0.000004513918,0.0001199676],"genre_scores_gemma":[0.99877274,0.0009868589,0.00006978296,0.000023826633,0.0000468134,0.000042563384,0.000008857464,0.00001158235,0.00003699521],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983576,0.0005702466,0.00018554537,0.00046135706,0.00017746458,0.00024777846],"domain_scores_gemma":[0.99908423,0.00031278902,0.00009861394,0.00016198041,0.00023969826,0.00010267632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010218028,0.00012150747,0.000340666,0.00029419636,0.000059160746,0.000009484111,0.00010092898,0.00011303298,0.00005968952],"category_scores_gemma":[0.00045744277,0.00012069735,0.000050696402,0.00033566912,0.00081571087,0.0000120557725,0.00013605248,0.00017071045,5.884532e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010289826,0.00017949291,0.123215035,0.000049083308,0.00046941347,8.9168446e-7,0.0007812141,0.000069223446,0.8721858,0.00010283276,0.000028343135,0.0018896381],"study_design_scores_gemma":[0.0024738929,0.0008363959,0.309921,0.000013349159,0.00028852138,0.0000019274605,0.0009988484,0.0069148084,0.67815286,0.00008867682,0.00014985626,0.00015990458],"about_ca_topic_score_codex":0.00009692093,"about_ca_topic_score_gemma":0.00004190408,"teacher_disagreement_score":0.19403301,"about_ca_system_score_codex":0.000024786108,"about_ca_system_score_gemma":0.00006787238,"threshold_uncertainty_score":0.4921895},"labels":[],"label_agreement":null},{"id":"W2005153559","doi":"10.1002/prp2.84","title":"Characterization of the 5‐HT<sub>2C</sub> receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet‐induced obesity","year":2014,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; Western University; Centre for Addiction and Mental Health; University of Toronto","funders":"","keywords":"Agonist; Pharmacology; 5-HT receptor; Medicine; Obesity; Receptor; Chemistry; Internal medicine; Serotonin","score_opus":0.06552505669109654,"score_gpt":0.37566570725492515,"score_spread":0.3101406505638286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005153559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942889,0.00015930354,0.000021544534,0.0036079285,0.0001388886,0.0012841158,0.000028033888,0.000020926844,0.00045034598],"genre_scores_gemma":[0.9983819,0.0011070429,0.000025471121,0.00016289824,0.00010837919,0.00008861773,0.00001100147,0.000019018857,0.00009566378],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99710894,0.0012768877,0.0003322152,0.0004516672,0.00041495115,0.00041532415],"domain_scores_gemma":[0.99855447,0.0005282798,0.00013260552,0.0002462348,0.00038625547,0.0001521469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015215164,0.00019499837,0.0004848771,0.0002996834,0.00024649844,0.000006574695,0.00019700476,0.00015759197,0.00006758258],"category_scores_gemma":[0.00037819307,0.00014633591,0.00009001249,0.00040188583,0.00082224,0.00009051932,0.00017095816,0.0007676045,0.000009566292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00939572,0.0024050518,0.007011241,0.0000933402,0.00017433839,0.0000066212747,0.003985797,0.00006870324,0.9752648,0.00040063632,0.00015629317,0.001037453],"study_design_scores_gemma":[0.0049648937,0.0013025049,0.13104674,0.000075512355,0.000098311284,0.000004750745,0.0003440216,0.001479694,0.86042845,0.00008764202,0.00007097833,0.000096479715],"about_ca_topic_score_codex":0.000032422373,"about_ca_topic_score_gemma":0.000034805238,"teacher_disagreement_score":0.1240355,"about_ca_system_score_codex":0.00030834982,"about_ca_system_score_gemma":0.00026251114,"threshold_uncertainty_score":0.59674054},"labels":[],"label_agreement":null},{"id":"W2015377426","doi":"10.1002/prp2.65","title":"Intranasal<scp>NAP</scp>(davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α‐synuclein","year":2014,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Paladin Labs (Canada)","funders":"National Institutes of Health; Yükseköğretim Kurulu; Michael J. Fox Foundation for Parkinson's Research","keywords":"Nap; Hyperphosphorylation; Cerebellum; Habituation; Striatum; Parkinson's disease; Internal medicine; Endocrinology; Medicine; Neuroscience; Biology; Chemistry; Phosphorylation; Disease; Biochemistry; Dopamine","score_opus":0.04998444665227508,"score_gpt":0.3868821000847844,"score_spread":0.3368976534325093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015377426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914712,0.0055473647,0.000074197334,0.00040821036,0.00008687258,0.00088943465,0.000021912125,0.000079804864,0.0014210406],"genre_scores_gemma":[0.997227,0.0011202685,0.00075022125,0.00012692707,0.00016750455,0.00019948745,0.00002288271,0.00005430744,0.00033141574],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99698716,0.00059049134,0.00028235427,0.0008299978,0.00048592035,0.0008240894],"domain_scores_gemma":[0.998312,0.00062213506,0.000077396755,0.00019181521,0.00032345607,0.00047322785],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007360263,0.0002975696,0.0004591204,0.0005191337,0.00035140882,0.0000923604,0.00014267751,0.00017065521,0.0001141912],"category_scores_gemma":[0.00036304543,0.00027886944,0.00008479996,0.00037602588,0.00044327928,0.00031758213,0.0001434081,0.00062637246,0.000027221491],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012068212,0.0028043578,0.025919275,0.000114633374,0.00025051378,0.0003281869,0.0052711703,0.000029895395,0.9506206,0.0009419861,0.0011695549,0.011343],"study_design_scores_gemma":[0.014080912,0.0027891246,0.51753014,0.00025844236,0.0005413667,0.0001662408,0.013408419,0.016864961,0.4263242,0.0040018135,0.0036276798,0.00040668342],"about_ca_topic_score_codex":0.0007675165,"about_ca_topic_score_gemma":0.000090530586,"teacher_disagreement_score":0.5242964,"about_ca_system_score_codex":0.00035437767,"about_ca_system_score_gemma":0.00023142202,"threshold_uncertainty_score":0.9999663},"labels":[],"label_agreement":null},{"id":"W2026195537","doi":"10.1002/prp2.4","title":"Green fluorescent protein fused to peptide agonists of two dissimilar G protein‐coupled receptors: novel ligands of the bradykinin B<sub>2</sub> (rhodopsin family) receptor and parathyroid hormone <scp>PTH</scp><sub>1</sub> (secretin family) receptor","year":2013,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université Laval","funders":"","keywords":"Internalization; G protein-coupled receptor; Receptor; Green fluorescent protein; Fusion protein; Parathyroid hormone; Agonist; HEK 293 cells; Parathyroid hormone receptor; Biology; Transfection; Cell biology; Biochemistry; Chemistry; Recombinant DNA; Hormone receptor; Calcium","score_opus":0.02483807847311671,"score_gpt":0.3022254399397686,"score_spread":0.2773873614666519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026195537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885151,0.0040333923,0.00043169237,0.0011607229,0.00023088606,0.005303935,0.00014705611,0.000049730726,0.00012750027],"genre_scores_gemma":[0.9936574,0.0017264934,0.0015836922,0.00016935144,0.0006916504,0.0016497703,0.00007265355,0.00015269387,0.00029630182],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99376184,0.0011100381,0.0009923255,0.0015745121,0.0010928347,0.0014684382],"domain_scores_gemma":[0.9962222,0.00026332063,0.0005072338,0.00080660614,0.0015454945,0.0006551597],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022326515,0.00072340824,0.00092192536,0.00042762756,0.0005421241,0.00011012355,0.0011496651,0.00050573895,0.00006151753],"category_scores_gemma":[0.0009889798,0.00060624955,0.00036593032,0.0010086538,0.0013095348,0.000063984946,0.00106133,0.0010909293,0.00004697767],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005783817,0.00074596866,0.00015333777,0.000109396075,0.00041340914,0.0000030074523,0.0023361095,0.000030366675,0.9825621,0.00013765022,0.01187547,0.0010547558],"study_design_scores_gemma":[0.0029087767,0.00204129,0.0019323133,0.00015702973,0.000057946483,0.000005719738,0.004080104,0.00022723676,0.9863073,0.00016863043,0.0017274286,0.0003861969],"about_ca_topic_score_codex":0.00026602665,"about_ca_topic_score_gemma":0.000033935292,"teacher_disagreement_score":0.010148041,"about_ca_system_score_codex":0.0002043546,"about_ca_system_score_gemma":0.0005768381,"threshold_uncertainty_score":0.9996389},"labels":[],"label_agreement":null},{"id":"W2033221635","doi":"10.1002/prp2.112","title":"Small caliber arterial endothelial cells calcium signals elicited by <scp>PAR</scp>2 are preserved from endothelial dysfunction","year":2015,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Faculty of Medicine, Memorial University of Newfoundland; Canadian Institutes of Health Research","keywords":"Endocrinology; Vasodilation; Acetylcholine; Internal medicine; Muscarinic acetylcholine receptor; Chemistry; Calcium in biology; Receptor; Transient receptor potential channel; Calcium; Angiotensin II; Voltage-dependent calcium channel; Mesenteric arteries; Endothelium; Biology; Medicine; Artery","score_opus":0.15102158370610735,"score_gpt":0.38515747102273995,"score_spread":0.2341358873166326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033221635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805452,0.0042242017,0.00021437378,0.0037312596,0.0023601113,0.0026003197,0.0011068,0.00031392122,0.004903796],"genre_scores_gemma":[0.9808798,0.00025835732,0.00027772228,0.0003784854,0.0066057085,0.00055008737,0.00010192461,0.00014265462,0.010805303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9922305,0.0025451616,0.0007109041,0.0013976354,0.00148835,0.0016274645],"domain_scores_gemma":[0.99372905,0.0019000401,0.00028947674,0.00058552716,0.0025309518,0.0009649288],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001935904,0.00058829837,0.0012405684,0.00058418995,0.00045596762,0.00013095277,0.000505829,0.00043218577,0.0005593174],"category_scores_gemma":[0.0019242243,0.00051195675,0.00031811904,0.00067997,0.0011917788,0.00025250966,0.0004680406,0.0013431415,0.0007191105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018190307,0.0006229589,0.0053002564,0.000019996223,0.0010185792,0.00023259541,0.0077598724,0.000014146469,0.6401157,0.0000066955895,0.34304526,0.000044926495],"study_design_scores_gemma":[0.01612292,0.0016187633,0.01125534,0.00010638773,0.0005330172,0.000063719956,0.015974257,0.00048689492,0.8806144,0.00026814846,0.07263136,0.0003248154],"about_ca_topic_score_codex":0.0018798201,"about_ca_topic_score_gemma":0.00009329891,"teacher_disagreement_score":0.2704139,"about_ca_system_score_codex":0.00087380165,"about_ca_system_score_gemma":0.000585908,"threshold_uncertainty_score":0.9997332},"labels":[],"label_agreement":null},{"id":"W2039851876","doi":"10.1002/prp2.124","title":"Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action","year":2015,"lang":"en","type":"review","venue":"Pharmacology Research & Perspectives","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carbamazepine; Pharmacology; Epilepsy; Medicine; Sodium channel; Oxcarbazepine; Anticonvulsant; Sodium channel blocker; Drug; Chemistry; Sodium","score_opus":0.5457133435388417,"score_gpt":0.5849949619644147,"score_spread":0.039281618425572984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039851876","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007216272,0.96903014,0.00009613216,0.0022291758,0.0019841413,0.01807034,0.0009247877,0.00014688793,0.00030212555],"genre_scores_gemma":[0.0097029125,0.9865181,0.000026237263,0.00010277732,0.00042821173,0.002146364,0.000007496841,0.000112789836,0.0009551039],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9889802,0.005789773,0.0007666461,0.0017389333,0.00140244,0.0013220255],"domain_scores_gemma":[0.9923183,0.0051041264,0.00052027893,0.0007246048,0.000982082,0.0003506299],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027874915,0.00060835265,0.0018312399,0.0011608476,0.0006754949,0.00005263769,0.0019821425,0.00029641442,0.0002567924],"category_scores_gemma":[0.00094000914,0.00037651695,0.0006010332,0.0018019109,0.0026263054,0.0003036893,0.00027939305,0.0012933282,0.00009184925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027135508,0.005445135,3.2690537e-7,0.0020608392,0.00029751088,0.00012244283,0.0011494114,0.000020348403,0.6459698,0.0054572793,0.002020781,0.33474258],"study_design_scores_gemma":[0.0017956748,0.012415951,7.891667e-7,0.00014049378,0.0004717293,0.00004937858,0.000316944,0.0004410845,0.5433776,0.0006985545,0.4400254,0.00026640538],"about_ca_topic_score_codex":0.000008588759,"about_ca_topic_score_gemma":0.000003045741,"teacher_disagreement_score":0.4380046,"about_ca_system_score_codex":0.00056121364,"about_ca_system_score_gemma":0.0015947777,"threshold_uncertainty_score":0.9998687},"labels":[],"label_agreement":null},{"id":"W2049745731","doi":"10.1002/prp2.119","title":"Pharmacological effects of recombinant human tissue kallikrein on bradykinin B<sub>2</sub>receptors","year":2015,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Bradykinin; Kallikrein; Recombinant DNA; B2 receptor; Receptor; Pharmacology; Medicine; Chemistry; Internal medicine; Biochemistry; Enzyme","score_opus":0.09456492252013282,"score_gpt":0.43950504607122426,"score_spread":0.34494012355109144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049745731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98379236,0.0043768794,0.0000149679145,0.0043820515,0.0014665038,0.0017760156,0.0000051886336,0.00018156879,0.0040044785],"genre_scores_gemma":[0.99544007,0.0008542766,0.00007622805,0.00038354666,0.00095913536,0.0002581868,0.000025816038,0.000068609574,0.0019341604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951543,0.001258614,0.00053524954,0.0008976235,0.0010838895,0.0010703283],"domain_scores_gemma":[0.99630725,0.0013364743,0.00017645991,0.0003144933,0.0010389556,0.0008263398],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018183107,0.0003939775,0.0008370895,0.0007600384,0.0003450111,0.000029020654,0.00039234376,0.00028299546,0.0006553],"category_scores_gemma":[0.0008808643,0.00034103665,0.00021811567,0.00088204903,0.0012929048,0.00018209592,0.00023563832,0.0011605003,0.0002815923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016540874,0.0033512805,0.0048331525,0.00016496208,0.0006043342,0.00040443672,0.006078641,0.000015306638,0.8649758,0.0029164383,0.108499005,0.006502551],"study_design_scores_gemma":[0.007901124,0.0071291663,0.018912178,0.0001341071,0.0002672108,0.000055334785,0.0017633722,0.00012402637,0.95329076,0.001667102,0.008406855,0.00034873709],"about_ca_topic_score_codex":0.00010795798,"about_ca_topic_score_gemma":0.0000110348155,"teacher_disagreement_score":0.10009215,"about_ca_system_score_codex":0.0005949844,"about_ca_system_score_gemma":0.0004973039,"threshold_uncertainty_score":0.99990416},"labels":[],"label_agreement":null},{"id":"W2068732634","doi":"10.1002/prp2.82","title":"Modulation of<scp>CYP</scp>3a expression and activity in mice models of type 1 and type 2 diabetes","year":2014,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Fonds de Recherche du Québec - Santé; Heart And Stroke Foundation Of Quebec; Heart and Stroke Foundation of Canada","keywords":"Type 2 diabetes; Modulation (music); Type (biology); Pharmacology; Expression (computer science); Diabetes mellitus; Computational biology; Chemistry; Medicine; Computer science; Biology; Endocrinology; Physics","score_opus":0.15960501819051987,"score_gpt":0.4788953691973568,"score_spread":0.31929035100683695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068732634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98615104,0.00982624,0.00004441209,0.000296612,0.00042395404,0.00055432477,0.000027462842,0.000024279527,0.002651679],"genre_scores_gemma":[0.9912126,0.008032892,0.00023686994,0.000089188914,0.00019522075,0.000041950687,0.0000049031123,0.000028997116,0.00015735177],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958171,0.002332476,0.0003489713,0.00055801775,0.0003025312,0.0006408585],"domain_scores_gemma":[0.9962939,0.0023536691,0.00017395377,0.00015615085,0.00075482833,0.00026751234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028771982,0.00023808604,0.0005200904,0.0005658161,0.00018912448,0.000013392152,0.0002700797,0.00030814248,0.000109624794],"category_scores_gemma":[0.0006411363,0.00023194472,0.000045161414,0.00074185577,0.0010843857,0.00026872795,0.00035212608,0.0010805664,0.000005929737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040368832,0.0005409414,0.015078336,0.00014222189,0.00012854711,0.0000031233958,0.0051626484,0.0016068231,0.9701122,0.00093046617,0.0008623318,0.005028679],"study_design_scores_gemma":[0.0028311745,0.0004064643,0.029691305,0.000028921004,0.00010254183,0.0000035331866,0.0009747489,0.12562905,0.8316816,0.0051068272,0.0034040853,0.0001397148],"about_ca_topic_score_codex":0.0000437173,"about_ca_topic_score_gemma":0.000007100685,"teacher_disagreement_score":0.13843057,"about_ca_system_score_codex":0.000052652187,"about_ca_system_score_gemma":0.00013064749,"threshold_uncertainty_score":0.9458431},"labels":[],"label_agreement":null},{"id":"W2069665729","doi":"10.1002/prp2.104","title":"Components of the endocannabinoid and dopamine systems are dysregulated in Huntington's disease: analysis of publicly available microarray datasets","year":2015,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research; Dalhousie University; British Pharmacological Society; King Abdulaziz University; Nova Scotia Health Research Foundation","keywords":"Huntington's disease; Microarray analysis techniques; Microarray; Gene expression; Endocannabinoid system; Dopaminergic; Disease; Neuroscience; Biology; Gene; Basal ganglia; Bioinformatics; Computational biology; Medicine; Dopamine; Central nervous system; Genetics; Pathology","score_opus":0.11517551667262194,"score_gpt":0.3802756652199151,"score_spread":0.2651001485472932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069665729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467313,0.0021044877,0.0000013697429,0.0010089068,0.00013786695,0.0007583287,0.0011068583,0.000015002717,0.00019405448],"genre_scores_gemma":[0.9992665,0.00015969397,0.000007449596,0.000043024902,0.00003050911,0.00008749884,0.000029166937,0.00001653108,0.00035959817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9947934,0.002760883,0.00036575555,0.0007888367,0.0007740459,0.0005170624],"domain_scores_gemma":[0.9978809,0.0004781849,0.00023679197,0.0005107732,0.00058553886,0.00030785412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010379642,0.00017870292,0.0004522302,0.0009443533,0.00014684691,0.000050342405,0.000726456,0.000039431394,0.000119132696],"category_scores_gemma":[0.002013506,0.00014112509,0.00008375849,0.0028092912,0.0016664694,0.00019043856,0.0005898947,0.00031816962,0.000006844441],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002911174,0.00063519157,0.151034,0.000057910504,0.00013739525,0.000015879936,0.0005630765,0.0011289311,0.8410983,0.00013683454,0.0048935935,0.000007784875],"study_design_scores_gemma":[0.001318066,0.00008644059,0.30026639,0.000025347272,0.0002301402,0.0000022919673,0.0023422202,0.0042003384,0.69071305,0.0000244784,0.000649724,0.00014154252],"about_ca_topic_score_codex":0.0005964384,"about_ca_topic_score_gemma":0.000086219596,"teacher_disagreement_score":0.15038526,"about_ca_system_score_codex":0.00012297748,"about_ca_system_score_gemma":0.0002671615,"threshold_uncertainty_score":0.6140176},"labels":[],"label_agreement":null},{"id":"W2078910840","doi":"10.1002/prp2.110","title":"Jadomycin breast cancer cytotoxicity is mediated by a copper‐dependent, reactive oxygen species–inducing mechanism","year":2015,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Canadian Cancer Society; Canadian Imperial Bank of Commerce; Beatrice Hunter Cancer Research Institute","keywords":"Reactive oxygen species; Cytotoxicity; Superoxide dismutase; Thioredoxin reductase; Thioredoxin; Chemistry; Catalase; Glutathione; Antioxidant; Biochemistry; Pharmacology; Intracellular; Molecular biology; Biology; Oxidative stress; Enzyme; In vitro","score_opus":0.07433736406191624,"score_gpt":0.3998172843808004,"score_spread":0.3254799203188842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078910840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762108,0.0055332575,0.00033174845,0.009983663,0.00063929823,0.0011569262,0.0013492883,0.00006039473,0.0047346707],"genre_scores_gemma":[0.9894062,0.0031257165,0.00007309053,0.0011479242,0.0009798035,0.00036830787,0.00008739021,0.000070458016,0.0047410587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964774,0.000572194,0.00025352236,0.0010357156,0.0006811572,0.0009799962],"domain_scores_gemma":[0.99781394,0.0000709776,0.00011449249,0.0003711987,0.0011004698,0.0005289432],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013233542,0.00032710662,0.00034195476,0.00020228389,0.00034063053,0.00006555679,0.0005687328,0.00030895195,0.0008462533],"category_scores_gemma":[0.00009125909,0.00031932307,0.0001231009,0.00036834602,0.0004052461,0.000024872616,0.00044537568,0.00072158105,0.000062015715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011334014,0.0003357716,0.00011228587,0.000008565809,0.0005085629,0.000018909555,0.0027067875,0.0000037249,0.9385014,0.00045296256,0.05596778,0.000249856],"study_design_scores_gemma":[0.0027600306,0.00056035357,0.00022834855,0.0000136282215,0.000056410645,0.000058413738,0.009958255,0.000103476734,0.96406984,0.0005733402,0.021236263,0.00038161434],"about_ca_topic_score_codex":0.00078099774,"about_ca_topic_score_gemma":0.00012976417,"teacher_disagreement_score":0.03473152,"about_ca_system_score_codex":0.00061045267,"about_ca_system_score_gemma":0.00084117125,"threshold_uncertainty_score":0.9999259},"labels":[],"label_agreement":null},{"id":"W2085716329","doi":"10.1002/prp2.72","title":"Bioequivalence of Sandoz methylphenidate osmotic‐controlled release tablet with Concerta<sup>®</sup> (Janssen‐Cilag)","year":2015,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Bioequivalence; Methylphenidate; Confidence interval; Crossover study; Pharmacology; Pharmacokinetics; Bioavailability; Geometric mean; Medicine; Chromatography; Chemistry; Attention deficit hyperactivity disorder; Mathematics; Internal medicine; Statistics; Placebo; Psychiatry","score_opus":0.16410638886954013,"score_gpt":0.46589983606464763,"score_spread":0.3017934471951075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085716329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972621,0.005126675,0.00034958823,0.010756719,0.00008900629,0.002269411,0.0000360786,0.00011702117,0.008634472],"genre_scores_gemma":[0.9938939,0.0007003851,0.0006743622,0.00022179529,0.00026933884,0.0003102929,0.000015526472,0.00006636387,0.0038480102],"study_design_codex":"bench_or_experimental","study_design_gemma":"qualitative","domain_scores_codex":[0.9945831,0.0015817134,0.0005061969,0.00087707094,0.0014225148,0.0010294503],"domain_scores_gemma":[0.9940797,0.0014217658,0.00020776031,0.00052368734,0.0030837054,0.0006833589],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026756297,0.00036021066,0.0011788253,0.00069940486,0.00022507727,0.00003820177,0.00037627915,0.00017816933,0.00228118],"category_scores_gemma":[0.002262284,0.00027895466,0.00021101715,0.0011954342,0.0020216072,0.0004282213,0.00020951251,0.0012884792,0.00021120171],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1412824,0.013547329,0.09121345,0.00095027185,0.009057482,0.0024753395,0.05397522,0.0053020525,0.61860776,0.0045047803,0.05644847,0.002635435],"study_design_scores_gemma":[0.28147265,0.016566932,0.0118430415,0.0006363695,0.0050605377,0.0013983748,0.52565205,0.056193043,0.078557886,0.0017339961,0.018463375,0.0024217614],"about_ca_topic_score_codex":0.00030104883,"about_ca_topic_score_gemma":0.000015359166,"teacher_disagreement_score":0.5400499,"about_ca_system_score_codex":0.00039699112,"about_ca_system_score_gemma":0.0014167113,"threshold_uncertainty_score":0.99996626},"labels":[],"label_agreement":null},{"id":"W2102730396","doi":"10.1002/prp2.25","title":"Mapping the sevoflurane‐binding sites of calmodulin","year":2014,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Anesthesia and Neurotoxicity Research","field":"Neuroscience","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Seventh Framework Programme; Uppsala Universitet; Akademiska Sjukhuset; Vetenskapsrådet; Swedish Foundation for International Cooperation in Research and Higher Education; European Commission","keywords":"Calmodulin; Sevoflurane; Pharmacology; Medicine; Chemistry; Internal medicine; Calcium","score_opus":0.22415069359699485,"score_gpt":0.440563575061218,"score_spread":0.21641288146422316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102730396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796175,0.00021766838,0.000061345134,0.009216019,0.00007479223,0.000787437,0.0000052472496,0.00006389487,0.009956146],"genre_scores_gemma":[0.99746555,0.00036151646,0.000033055676,0.0003140324,0.0002909293,0.00013704518,5.2397365e-7,0.000023632803,0.0013737186],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9934117,0.0036973532,0.00025490503,0.0006598176,0.0010570068,0.00091917557],"domain_scores_gemma":[0.99352807,0.0055525666,0.0000787484,0.00034919457,0.00031978494,0.00017164374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032889189,0.00016844047,0.00027994742,0.00050258543,0.00088548986,0.00005939996,0.0011280292,0.00009418971,0.00074523076],"category_scores_gemma":[0.002948478,0.00011975633,0.00011752991,0.0012950996,0.001981307,0.00018526099,0.00036432993,0.0013450409,0.0003064571],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016265549,0.00019599132,0.0016329221,0.000033179036,0.000015350997,0.00003462933,0.006022996,0.00001611548,0.9836957,0.0050510406,0.0025519277,0.00058749807],"study_design_scores_gemma":[0.0005904262,0.00033199321,0.0027104598,0.000013678515,0.000006040492,0.0000728197,0.004395512,0.002842737,0.97887886,0.0010275537,0.0089885,0.00014142464],"about_ca_topic_score_codex":0.00003364971,"about_ca_topic_score_gemma":0.00000414083,"teacher_disagreement_score":0.017848095,"about_ca_system_score_codex":0.000090271365,"about_ca_system_score_gemma":0.00012263637,"threshold_uncertainty_score":0.8159754},"labels":[],"label_agreement":null},{"id":"W2394916837","doi":"10.1002/prp2.203","title":"Benzolamide improves oxygenation and reduces acute mountain sickness during a high‐altitude trek and has fewer side effects than acetazolamide at sea level","year":2016,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"High Altitude and Hypoxia","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surrey Place Centre","funders":"National Institutes of Health; University of Liverpool","keywords":"Acetazolamide; Effects of high altitude on humans; Altitude (triangle); Oxygenation; Medicine; Side effect (computer science); Hyperbaric oxygenation; Altitude sickness; Acute exposure; Anesthesia; Internal medicine; Computer science; Mathematics","score_opus":0.030404702924347656,"score_gpt":0.33972132171086433,"score_spread":0.3093166187865167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394916837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99030215,0.0044321977,0.000044828288,0.0040951194,0.00013158197,0.0006775523,0.000074994554,0.000036515146,0.00020503812],"genre_scores_gemma":[0.9915144,0.0044693714,0.00019962588,0.00008380081,0.00049843243,0.00023090032,0.000024541585,0.000047298978,0.0029316538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99721766,0.0005004918,0.00021219839,0.0009633664,0.00031876465,0.00078753557],"domain_scores_gemma":[0.99883866,0.00023969241,0.00008109787,0.00024382342,0.00032299623,0.0002737209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006372449,0.00030129094,0.00031283582,0.00024653997,0.00072762644,0.000091735776,0.00026823164,0.00021386982,0.00003560341],"category_scores_gemma":[0.00023737278,0.00023149891,0.00006874479,0.00015514393,0.0011670713,0.00005325795,0.00064337626,0.00028565622,0.000020446614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010032144,0.00013314691,0.0033126816,0.00006521635,0.00058001315,0.000065460845,0.0011923352,0.0000011698663,0.99144655,0.00019750277,0.0008635061,0.0011392154],"study_design_scores_gemma":[0.002647948,0.00046253557,0.16686922,0.00002495409,0.00007725687,0.00006671923,0.00046352035,0.000011560155,0.8280875,0.00024761763,0.0007669234,0.0002742322],"about_ca_topic_score_codex":0.00016712298,"about_ca_topic_score_gemma":0.00043285993,"teacher_disagreement_score":0.16355653,"about_ca_system_score_codex":0.00018738688,"about_ca_system_score_gemma":0.00016518855,"threshold_uncertainty_score":0.94402516},"labels":[],"label_agreement":null},{"id":"W2398714949","doi":"10.1002/prp2.233","title":"Niacin promotes revascularization and recovery of limb function in diet‐induced obese mice with peripheral ischemia","year":2016,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Robarts Clinical Trials; Western University","funders":"Canadian Diabetes Association; Heart and Stroke Foundation of Canada","keywords":"Niacin; Medicine; Hypoxia (environmental); Hyperlipidemia; Revascularization; Internal medicine; Ischemia; Metabolic syndrome; Endocrinology; Hindlimb; Critical limb ischemia; Inflammation; Surgery; Pharmacology; Obesity; Diabetes mellitus; Chemistry","score_opus":0.028898392430357606,"score_gpt":0.3443824754477712,"score_spread":0.3154840830174136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398714949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909017,0.0055377577,0.00013040446,0.0017942713,0.000038239,0.0007794365,0.000005674163,0.000024601055,0.00078792864],"genre_scores_gemma":[0.99772245,0.0014189162,0.00009237912,0.000030015159,0.00017200332,0.000088615954,0.0000048036354,0.000019283914,0.00045154142],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99828756,0.00044635456,0.0001546831,0.0004358957,0.00035381134,0.000321717],"domain_scores_gemma":[0.99912536,0.00016798453,0.000039865146,0.00018004717,0.00033857828,0.00014818169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000757709,0.00012571916,0.0003140915,0.00028230948,0.00008212522,0.000010803769,0.000061486826,0.0001001199,0.00015896976],"category_scores_gemma":[0.000200622,0.00008519287,0.00011026854,0.00040877276,0.00032820104,0.00021798677,0.0000716159,0.00032700217,0.0000044962694],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00890242,0.00045796984,0.030953513,0.00016135573,0.0007537558,0.000059078273,0.0008775673,0.000001473467,0.95407724,0.00007463709,0.00013524748,0.0035457313],"study_design_scores_gemma":[0.012311857,0.0069957743,0.48792475,0.00049806427,0.00075146114,0.00010805013,0.0030563811,0.000096597796,0.48727533,0.0003004943,0.00037021795,0.00031103916],"about_ca_topic_score_codex":0.000054029955,"about_ca_topic_score_gemma":0.000020956013,"teacher_disagreement_score":0.46680194,"about_ca_system_score_codex":0.00015338324,"about_ca_system_score_gemma":0.00020184947,"threshold_uncertainty_score":0.34740645},"labels":[],"label_agreement":null},{"id":"W2475211826","doi":"10.1002/prp2.243","title":"An inhaled dose of budesonide induces genes involved in transcription and signaling in the human airways: enhancement of anti‐ and proinflammatory effector genes","year":2016,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Canadian Institutes of Health Research; Alberta Innovates; Alberta Innovates - Health Solutions; AstraZeneca","keywords":"Budesonide; Proinflammatory cytokine; Gene expression; Biology; Gene; Signal transduction; Glucocorticoid receptor; Immunology; Medicine; Pharmacology; Inflammation; Glucocorticoid; Cell biology; Asthma; Genetics","score_opus":0.06214116730083403,"score_gpt":0.36863454068373736,"score_spread":0.30649337338290333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2475211826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885959,0.010129357,0.0000072789803,0.00019068073,0.000069051035,0.00087007915,0.00006811113,0.000012223254,0.000057308873],"genre_scores_gemma":[0.99581933,0.0038863004,0.000021958318,0.000011781758,0.00004634223,0.00016888468,0.000007064054,0.000012025499,0.00002632317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99647075,0.0022124054,0.0003613498,0.00041554964,0.000099441226,0.00044048834],"domain_scores_gemma":[0.998969,0.0005508948,0.00010319645,0.00015508587,0.00019170152,0.000030083622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023649996,0.00016861975,0.0003792488,0.0004962875,0.00017534703,0.000009220903,0.0002594958,0.00017164128,0.000085985754],"category_scores_gemma":[0.000079582634,0.00010959459,0.00003665925,0.0002555169,0.0014515892,0.00022835634,0.00006608551,0.00036830295,0.000003816647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044712596,0.00052612816,0.02391721,0.00014145972,0.00009050045,0.000014885335,0.023134777,7.5518506e-7,0.94880784,0.00034647674,0.000018443268,0.0025544174],"study_design_scores_gemma":[0.0030237534,0.00091076404,0.052039463,0.00009762296,0.000021939351,0.000009626773,0.012138019,0.000002336695,0.9312734,0.00020228105,0.0001638531,0.000116944306],"about_ca_topic_score_codex":0.00024117029,"about_ca_topic_score_gemma":0.00036440932,"teacher_disagreement_score":0.028122254,"about_ca_system_score_codex":0.00006787985,"about_ca_system_score_gemma":0.00012814892,"threshold_uncertainty_score":0.53484404},"labels":[],"label_agreement":null},{"id":"W2589043796","doi":"10.1002/prp2.298","title":"Antibiotic-associated suspected adverse drug reactions among hospitalized patients in Uganda: a prospective cohort study","year":2017,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; African Population and Health Research Center; International Development Research Centre; Wellcome Trust; Wellcome","keywords":"Medicine; Ethambutol; Rifampicin; Pyrazinamide; Prospective cohort study; Incidence (geometry); Antibiotics; Internal medicine; Isoniazid; Tuberculosis; Toxic epidermal necrolysis; Rash; Ceftriaxone; Pediatrics; Dermatology","score_opus":0.019131309753483473,"score_gpt":0.35882988938846544,"score_spread":0.33969857963498196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589043796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98401845,0.00049531524,9.079777e-7,0.00043005173,0.0008937494,0.0037500914,0.000047656882,0.00013364799,0.010230132],"genre_scores_gemma":[0.99110806,0.00056391663,0.0000069839766,0.000012398477,0.000072682764,0.00013080164,0.000035902172,0.000045028453,0.00802425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99508315,0.0018186367,0.00049664214,0.001147691,0.00025358004,0.0012003175],"domain_scores_gemma":[0.9973551,0.00040067395,0.00036203157,0.00068443606,0.0011019625,0.00009578564],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["sts"],"category_scores_codex":[0.0019527182,0.00035530524,0.00071255775,0.0005786387,0.0023170135,0.000078465135,0.0009064147,0.00030760438,0.0010587303],"category_scores_gemma":[0.0016001143,0.00032221983,0.0001494669,0.0004910914,0.0027725087,0.00050672266,0.0004825974,0.0018001196,0.0003353232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087182154,0.0070045125,0.96786,0.000015626112,0.0012992289,0.00012957522,0.009834201,0.0000016266487,0.009232023,0.00015528293,0.0035714149,0.000024675728],"study_design_scores_gemma":[0.009194233,0.00056473806,0.96772814,0.00007175203,0.00012316233,0.0000024458166,0.01642934,0.000006198619,0.0053020036,0.00012206125,0.00012984454,0.00032605304],"about_ca_topic_score_codex":0.005611992,"about_ca_topic_score_gemma":0.0044974643,"teacher_disagreement_score":0.008322412,"about_ca_system_score_codex":0.0008389943,"about_ca_system_score_gemma":0.00024323633,"threshold_uncertainty_score":0.99994135},"labels":[],"label_agreement":null},{"id":"W2605599884","doi":"10.1002/prp2.305","title":"Physiologically based pharmacokinetic modeling of tea catechin mixture in rats and humans","year":2017,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Tea Polyphenols and Effects","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Simon Fraser University","funders":"National Cancer Institute; U.S. Public Health Service; South China Normal University","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; Catechin; Pharmacology; Chemistry; Epigallocatechin gallate; Polyphenol; Chromatography; Biochemistry; Medicine; Antioxidant","score_opus":0.10895113559059927,"score_gpt":0.4700390199096659,"score_spread":0.36108788431906663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605599884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989023,0.0023812484,0.00004076105,0.005057378,0.00007820774,0.00080080825,0.000007983339,0.00003283853,0.0025777908],"genre_scores_gemma":[0.9984781,0.0006137845,0.00026603765,0.00013482892,0.0002176843,0.00009729879,0.000003106901,0.000021305124,0.0001678672],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99804264,0.0003991318,0.00021081617,0.00049684907,0.00030107403,0.000549462],"domain_scores_gemma":[0.99889505,0.0002577155,0.00007541108,0.00031227266,0.0002759192,0.00018362862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010265656,0.00017425757,0.00044046258,0.00032341975,0.00034522085,0.000028738084,0.00030884577,0.00012784179,0.00027323596],"category_scores_gemma":[0.00039516593,0.000138395,0.00007134942,0.00013910269,0.00091229944,0.00011253387,0.00020632234,0.00097284315,0.000008124115],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013650021,0.0007328659,0.007457372,0.00018698921,0.00008919814,0.00015344632,0.002321749,0.0003438775,0.9851461,0.00016494801,0.00076301413,0.001275446],"study_design_scores_gemma":[0.020082347,0.0036938784,0.37564358,0.000492894,0.00028738772,0.00004432745,0.005024988,0.2961423,0.2945062,0.0029164567,0.00045625464,0.00070938753],"about_ca_topic_score_codex":0.0003149403,"about_ca_topic_score_gemma":0.00002930628,"teacher_disagreement_score":0.6906399,"about_ca_system_score_codex":0.00009928845,"about_ca_system_score_gemma":0.000163869,"threshold_uncertainty_score":0.5643585},"labels":[],"label_agreement":null},{"id":"W2617629258","doi":"10.1002/prp2.321","title":"Clinician agreement and influence of medication‐related characteristics on assessment of polypharmacy","year":2017,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Polypharmacy; Medicine; Beers Criteria; Logistic regression; Medication therapy management; Comorbidity; Multivariate analysis; Emergency medicine; Intensive care medicine; Internal medicine; Family medicine; Pharmacy","score_opus":0.24602101374487487,"score_gpt":0.6049979247719577,"score_spread":0.35897691102708285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617629258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772939,0.00037041612,0.000004700012,0.012075496,0.00017542344,0.00075794593,0.000025311349,0.0000114105005,0.009285383],"genre_scores_gemma":[0.99549365,0.0036043292,0.00015565736,0.00026826857,0.00010162153,0.000035213303,0.0000052610344,0.000012001193,0.00032398166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766827,0.0005082539,0.00048025567,0.00033950518,0.000671567,0.00033214898],"domain_scores_gemma":[0.9970552,0.0011524415,0.00047040035,0.00037137506,0.0006815462,0.00026905266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002305847,0.00013287831,0.00043034062,0.00025613725,0.00030942197,0.000018493758,0.0003037286,0.00007946967,0.00070529716],"category_scores_gemma":[0.0014328172,0.00011031202,0.0000708211,0.00011019938,0.001624366,0.00021564426,0.00024166876,0.0008852372,0.00001505599],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013385967,0.002295506,0.84191793,0.0003597785,0.0008960706,0.00006064523,0.002525692,0.000005177584,0.13708465,0.003432655,0.0005254551,0.009557826],"study_design_scores_gemma":[0.0033510637,0.0011512755,0.98179066,0.000106221385,0.00020507936,0.000009648366,0.0007143798,0.001497585,0.009545063,0.00018016265,0.0013578298,0.00009105723],"about_ca_topic_score_codex":0.00008229868,"about_ca_topic_score_gemma":0.0000014044973,"teacher_disagreement_score":0.13987269,"about_ca_system_score_codex":0.00010195074,"about_ca_system_score_gemma":0.00028425764,"threshold_uncertainty_score":0.77225095},"labels":[],"label_agreement":null},{"id":"W2622074191","doi":"10.1002/prp2.328","title":"A serious nightmare: psychiatric and neurologic adverse reactions to mefloquine are serious adverse reactions","year":2017,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mefloquine; Medicine; Malaria prophylaxis; Psychiatry; Drug; Adverse effect; Nightmare; Malaria; Intensive care medicine; Chloroquine; Pharmacology; Pathology","score_opus":0.0727304260021628,"score_gpt":0.44966940972235636,"score_spread":0.3769389837201936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622074191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90668505,0.0012368675,0.000010520537,0.07955512,0.00072039186,0.0022142353,0.000046644796,0.000223907,0.009307237],"genre_scores_gemma":[0.9890795,0.0030217818,0.00027464103,0.0017077698,0.0009356715,0.0005721737,0.000004485538,0.00004241623,0.0043616067],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9962326,0.0006724431,0.00036837175,0.001093607,0.00053659803,0.0010963365],"domain_scores_gemma":[0.99701744,0.00060130475,0.00022023931,0.0005944946,0.00071944366,0.00084707234],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0012151345,0.00037935158,0.0006815164,0.000680141,0.0031633205,0.000064414875,0.0004338772,0.00022998355,0.0008022546],"category_scores_gemma":[0.0018397553,0.0003088823,0.00019066894,0.0005581638,0.0014246216,0.00035677067,0.00072653405,0.0019231862,0.0002480705],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01496864,0.0079283,0.084494516,0.0007537258,0.0030230102,0.0065436955,0.008887233,0.00015976549,0.68922234,0.0013774728,0.17682956,0.0058117732],"study_design_scores_gemma":[0.007592607,0.0052910084,0.80990165,0.000051036754,0.00065850455,0.00067511294,0.006535772,0.00042950117,0.0029807258,0.00067084545,0.16459638,0.0006168585],"about_ca_topic_score_codex":0.00034662825,"about_ca_topic_score_gemma":0.00013713451,"teacher_disagreement_score":0.7254071,"about_ca_system_score_codex":0.00034408254,"about_ca_system_score_gemma":0.00018060218,"threshold_uncertainty_score":0.99993634},"labels":[],"label_agreement":null},{"id":"W2748667807","doi":"10.1002/prp2.339","title":"Nerve growth factor inhibitor with novel‐binding domain demonstrates nanomolar efficacy in both cell‐based and cell‐free assay systems","year":2017,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Nerve injury and regeneration","field":"Neuroscience","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Laurentian University","funders":"","keywords":"Nerve growth factor; Neurotrophin; Tropomyosin receptor kinase A; Diabetic neuropathy; Pharmacology; Growth factor; Population; Chemistry; Medicine; Neuroscience; Biology; Internal medicine; Endocrinology; Receptor; Diabetes mellitus","score_opus":0.07623188463163862,"score_gpt":0.37608691175752007,"score_spread":0.29985502712588147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748667807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941114,0.0005383124,0.00013488591,0.0015770044,0.0003363665,0.001133432,0.00010013258,0.0000554594,0.002012976],"genre_scores_gemma":[0.9986144,0.000103396036,0.00021700603,0.000030486342,0.00033851614,0.00015473642,0.0000024975147,0.000039296825,0.00049968774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99583447,0.0014947868,0.0002731254,0.0009819908,0.00058281445,0.0008328378],"domain_scores_gemma":[0.99763143,0.0013032407,0.0001967025,0.00042620962,0.00019128222,0.00025114632],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0015540888,0.00028451177,0.00033700824,0.00048715368,0.0017129463,0.00053662085,0.0008112808,0.00016611512,0.00004996237],"category_scores_gemma":[0.00053655513,0.00022655973,0.000055860986,0.0003195741,0.0016225728,0.0007015891,0.0002845622,0.0009888554,0.000014195346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044654787,0.00083721994,0.00558301,0.00008671088,0.000013320774,0.00023396316,0.00140037,0.000060055292,0.98992556,0.0010437969,0.00034363926,0.000025777032],"study_design_scores_gemma":[0.0042705717,0.0005624088,0.004512849,0.000054051183,0.000013571382,0.000026126047,0.0016285463,0.0010512493,0.9874087,0.000071805414,0.00010685961,0.00029328975],"about_ca_topic_score_codex":0.00018492834,"about_ca_topic_score_gemma":0.00005303331,"teacher_disagreement_score":0.004502946,"about_ca_system_score_codex":0.00024738966,"about_ca_system_score_gemma":0.00032504997,"threshold_uncertainty_score":0.9995867},"labels":[],"label_agreement":null},{"id":"W2758755118","doi":"10.1002/prp2.346","title":"Coffee inhibition of <scp>CYP</scp>3A4 in vitro was not translated to a grapefruit‐like pharmacokinetic interaction clinically","year":2017,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Coffee research and impacts","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"London Health Sciences Centre; Heart and Stroke Foundation of Canada","keywords":"Felodipine; Grapefruit juice; Cmax; Pharmacology; Chemistry; Bioavailability; Pharmacokinetics; CYP3A4; Crossover study; In vitro; Drug interaction; Oral administration; Metabolism; Medicine; Biochemistry; Internal medicine; Cytochrome P450","score_opus":0.1396343866223276,"score_gpt":0.510399854943438,"score_spread":0.37076546832111035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758755118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770884,0.0007102961,0.00004308286,0.0136089865,0.00033710085,0.0022878111,0.000057138244,0.00006327413,0.0058038896],"genre_scores_gemma":[0.99594927,0.001531982,0.0002062788,0.00046221723,0.0004553076,0.00026494384,0.000024689802,0.000053198168,0.0010521016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99491316,0.0010750665,0.00071038696,0.00083457725,0.0011178886,0.0013489032],"domain_scores_gemma":[0.99518496,0.0018428101,0.00020459968,0.0005652899,0.0012785131,0.00092380086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032408584,0.00030153475,0.0007603899,0.0016185512,0.00039909137,0.000097113276,0.00051205116,0.00020804175,0.00050629565],"category_scores_gemma":[0.004366189,0.0002816087,0.00024501444,0.0007704153,0.0011291931,0.0004996638,0.0002972424,0.002214013,0.00017699524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00850195,0.0017629821,0.0022389889,0.00016887122,0.00030792315,0.00038889292,0.0076679657,0.0000065093923,0.9578622,0.000018290411,0.009249491,0.011825917],"study_design_scores_gemma":[0.011442034,0.0036238942,0.08020333,0.0002283687,0.00012946638,0.0000829269,0.0032932495,0.0013867001,0.8931145,0.00017997048,0.0061626513,0.00015289216],"about_ca_topic_score_codex":0.00042782087,"about_ca_topic_score_gemma":0.00006348517,"teacher_disagreement_score":0.07796434,"about_ca_system_score_codex":0.0004956691,"about_ca_system_score_gemma":0.0006608383,"threshold_uncertainty_score":0.9999636},"labels":[],"label_agreement":null},{"id":"W2780903570","doi":"10.1002/prp2.375","title":"Natriuretic peptide receptor‐C‐mediated attenuation of vascular smooth muscle cell hypertrophy involves Gqα/PLCβ1 proteins and ROS‐associated signaling","year":2017,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Heart and Stroke Foundation of Canada","keywords":"Vascular smooth muscle; Internal medicine; Endocrinology; Atrial natriuretic peptide; Muscle hypertrophy; NADPH oxidase; Angiotensin II; Gq alpha subunit; NOX4; Receptor; Signal transduction; P22phox; G protein; Brain natriuretic peptide; Protein kinase B; Natriuretic peptide; Chemistry; Phosphorylation; Oxidative stress; Medicine; Biochemistry; Heart failure","score_opus":0.04932501334108497,"score_gpt":0.3679216718421438,"score_spread":0.31859665850105884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2780903570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896896,0.0052423826,0.00002126815,0.0018948594,0.00013446256,0.0015262091,0.000024093812,0.00006934379,0.0013977756],"genre_scores_gemma":[0.9958652,0.0025327909,0.00044431866,0.00007204351,0.00036190546,0.00017222865,0.000021773829,0.000051436687,0.0004782697],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968937,0.0008089161,0.00031561468,0.0005899794,0.00072119717,0.0006705873],"domain_scores_gemma":[0.9971705,0.0008828334,0.00024377267,0.00040429088,0.0010116918,0.00028688484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021386007,0.00023559107,0.0005542016,0.00047718463,0.0006844617,0.000058412676,0.00030233763,0.00021266802,0.00030945684],"category_scores_gemma":[0.002784776,0.00021048756,0.00015202264,0.00034019374,0.0011407826,0.00024193457,0.00021056503,0.0009248469,0.00005320985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045795584,0.00068178785,0.011001061,0.00021901962,0.0002956471,0.000051838186,0.0038783527,0.000008160151,0.98152864,0.00003200763,0.0012332774,0.0006122245],"study_design_scores_gemma":[0.02056568,0.004155219,0.24196702,0.0004940987,0.0007315438,0.00001044812,0.01315799,0.0022561236,0.7113339,0.00081881054,0.003744019,0.000765169],"about_ca_topic_score_codex":0.0004605133,"about_ca_topic_score_gemma":0.000017788647,"teacher_disagreement_score":0.2701948,"about_ca_system_score_codex":0.0002776497,"about_ca_system_score_gemma":0.00030747132,"threshold_uncertainty_score":0.85834336},"labels":[],"label_agreement":null},{"id":"W2892725021","doi":"10.1002/prp2.426","title":"Methods for the assessment of selection bias in drug safety during pregnancy studies using electronic medical data","year":2018,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"Canadian Institutes of Health Research; Université de Montréal","keywords":"Drug; Selection (genetic algorithm); Medicine; Pregnancy; Selection bias; Medical physics; Computer science; Reliability engineering; Pharmacology; Artificial intelligence; Engineering","score_opus":0.4334340790686059,"score_gpt":0.671147942719841,"score_spread":0.2377138636512351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892725021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.738076,0.15854067,0.049223788,0.042447448,0.0011276202,0.008246816,0.000049161856,0.00015027414,0.002138244],"genre_scores_gemma":[0.97574073,0.01720749,0.005924494,0.000060166007,0.0005343879,0.00022371387,0.000006259859,0.000020011046,0.0002827541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962834,0.0015815103,0.0003818457,0.0004864887,0.0005782295,0.00068848766],"domain_scores_gemma":[0.9946212,0.003781147,0.00012652573,0.00041323947,0.00090384623,0.00015401488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008136239,0.00012965483,0.00038066698,0.00036781534,0.0004080774,0.000006938064,0.00047937405,0.000085250904,0.00043878917],"category_scores_gemma":[0.0048449296,0.00008853643,0.00005843099,0.0007888202,0.0013215977,0.00018683236,0.0003576187,0.0009251113,0.0000014432679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070021963,0.004929979,0.054913383,0.0027009805,0.009144265,0.00007123232,0.07357188,0.000052801875,0.70775574,0.0105005875,0.008524919,0.120832],"study_design_scores_gemma":[0.032808237,0.0048638005,0.24442366,0.006610008,0.0019463894,0.0008468977,0.0904337,0.28036293,0.31346476,0.0048270277,0.01850944,0.00090310944],"about_ca_topic_score_codex":0.00009991584,"about_ca_topic_score_gemma":0.00014856984,"teacher_disagreement_score":0.39429098,"about_ca_system_score_codex":0.0008235954,"about_ca_system_score_gemma":0.002202041,"threshold_uncertainty_score":0.58001834},"labels":[],"label_agreement":null},{"id":"W2910588927","doi":"10.1002/prp2.453","title":"Development and validation of PART (Pharmacotherapy Assessment in Renal Transplant Patients) criteria to assess drug‐related problems in an outpatient renal transplant population: A cross‐sectional study","year":2019,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Santé Montérégie; Université de Montréal; Centre Hospitalier de l’Université de Montréal; Centre intégré de santé et de services sociaux de la Montérégie-Centre; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Intégré de Santé et de Services Sociaux des Laurentides","funders":"Université de Montréal","keywords":"Medicine; Pharmacotherapy; Cross-sectional study; Intensive care medicine; Drug; Kidney transplantation; Population; Kidney transplant; Internal medicine; Transplantation; Emergency medicine; Pharmacology; Pathology","score_opus":0.20879522921868185,"score_gpt":0.5235513994274298,"score_spread":0.3147561702087479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910588927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944731,0.00009672292,0.000011518081,0.00044760507,0.00028758252,0.0043507363,0.00003947301,0.000024744799,0.00026853828],"genre_scores_gemma":[0.99874,0.000101146696,0.00032861755,0.000087264496,0.000054183267,0.000429684,0.0001390092,0.000027096727,0.0000930049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953088,0.0014607132,0.00093085616,0.0007498783,0.000996381,0.00055337197],"domain_scores_gemma":[0.99856484,0.0004301675,0.000148025,0.00015332871,0.00040687723,0.0002967516],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030070932,0.00024824427,0.00048747184,0.00081118825,0.00013073404,0.000050899147,0.00016889661,0.00010559907,0.0010899799],"category_scores_gemma":[0.000033703574,0.00022119166,0.00005438018,0.0006053666,0.00011657062,0.0004999945,0.00005458266,0.0010413056,0.00001069765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031218256,0.006566383,0.9261457,0.00012397495,0.00019424036,0.000034757093,0.034242183,0.0005471526,0.02863008,0.00003904267,0.000019685056,0.0003350027],"study_design_scores_gemma":[0.011210928,0.002051758,0.977383,0.0001288405,0.000048355098,0.0000093133385,0.0015608858,0.0017010726,0.005401441,0.00002532215,0.00025840153,0.00022065417],"about_ca_topic_score_codex":0.00020222885,"about_ca_topic_score_gemma":0.00015147062,"teacher_disagreement_score":0.051237356,"about_ca_system_score_codex":0.0005509319,"about_ca_system_score_gemma":0.00025748604,"threshold_uncertainty_score":0.99982315},"labels":[],"label_agreement":null},{"id":"W2940964849","doi":"10.1002/prp2.475","title":"The effect of chronic kidney disease on <scp>CYP</scp>2B expression and activity in male Wistar rats","year":2019,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation","keywords":"Kidney disease; Renal function; Pharmacokinetics; Endocrinology; Metabolite; Internal medicine; Bupropion; Kidney; Medicine; Pharmacology; Population; Western blot; Chemistry; Pathology; Biochemistry","score_opus":0.06449477313228555,"score_gpt":0.46828558648771107,"score_spread":0.40379081335542555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940964849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97433877,0.014552905,0.0000023922412,0.0017163359,0.0012359694,0.0021777418,0.00013863386,0.00004011945,0.005797138],"genre_scores_gemma":[0.986134,0.009566712,0.0000069444977,0.00025657794,0.00048817255,0.00042899372,0.0000077181785,0.000050110622,0.0030607914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9907971,0.005998397,0.0003770813,0.00091262656,0.0005899706,0.001324832],"domain_scores_gemma":[0.99109715,0.0071994276,0.0001773226,0.00041286336,0.00023302584,0.00088021066],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0047049397,0.00042330913,0.00058768643,0.0004815652,0.00062567566,0.00004517961,0.0007264342,0.00024971215,0.00092479034],"category_scores_gemma":[0.0009105898,0.0003141595,0.0001624944,0.0006040889,0.0015758782,0.00020281975,0.0005339086,0.0026642047,0.00019423482],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036539852,0.0007773074,0.030361628,0.0002540945,0.00024373457,0.00011755631,0.0016380856,0.00038453023,0.93989605,0.0004182709,0.017908204,0.0043465705],"study_design_scores_gemma":[0.007385003,0.0013400877,0.014815807,0.00006129844,0.00013543318,0.000011231512,0.00057891855,0.0051596947,0.86898047,0.00030802604,0.101035215,0.0001888026],"about_ca_topic_score_codex":0.000032391425,"about_ca_topic_score_gemma":0.000010297345,"teacher_disagreement_score":0.08312701,"about_ca_system_score_codex":0.000316496,"about_ca_system_score_gemma":0.00048124435,"threshold_uncertainty_score":0.9999885},"labels":[],"label_agreement":null},{"id":"W2972774762","doi":"10.1002/prp2.524","title":"Phenolic acid phenethylesters and their corresponding ketones: Inhibition of 5‐lipoxygenase and stability in human blood and HepaRG cells","year":2019,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Essential Oils and Antimicrobial Activity","field":"Agricultural and Biological Sciences","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute; Université de Moncton","funders":"Natural Sciences and Engineering Research Council of Canada; New Brunswick Innovation Foundation; Fondation de la recherche en santé du Nouveau-Brunswick","keywords":"Ketone; Arachidonic acid; Biosynthesis; Chemistry; Caffeic acid phenethyl ester; Arachidonate 5-lipoxygenase; Leukotriene; Biochemistry; Lipoxygenase; Caffeic acid; Enzyme; Stereochemistry; Biology; Antioxidant; Organic chemistry","score_opus":0.03629642873443912,"score_gpt":0.31530857724963623,"score_spread":0.2790121485151971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972774762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772143,0.00096782076,2.805894e-7,0.00068875414,0.000036042224,0.00039733876,0.00003969026,0.0000125087,0.00013614321],"genre_scores_gemma":[0.9989909,0.00087106164,0.000008764371,0.000027028234,0.00006332056,0.000011794961,0.000004019456,0.0000015492232,0.0000215925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844307,0.0005301262,0.00015407008,0.00043890977,0.0001093107,0.00032452462],"domain_scores_gemma":[0.9992452,0.00046943573,0.000056312623,0.000037477435,0.00009335181,0.000098195385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008353886,0.00012661697,0.0002517372,0.000062577354,0.00019044666,0.000041196447,0.00008052252,0.00009843263,0.00018902679],"category_scores_gemma":[0.000026920203,0.000061039435,0.000029827745,0.00027257315,0.0006593622,0.00021010202,0.00020884503,0.00037837916,0.0000013372223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000163156,0.0003115312,0.018760072,0.000049176993,0.000020429829,0.0000041849034,0.0033424431,3.8924566e-7,0.9761267,0.00009624714,0.0000151777,0.001110525],"study_design_scores_gemma":[0.0005629215,0.00039991952,0.053182386,0.000026385966,0.000007963567,0.0000051126717,0.0072526615,0.000033951044,0.9380301,0.00034946707,0.00003882915,0.00011026032],"about_ca_topic_score_codex":0.00054829766,"about_ca_topic_score_gemma":0.00040508233,"teacher_disagreement_score":0.038096525,"about_ca_system_score_codex":0.000025258589,"about_ca_system_score_gemma":0.000012408801,"threshold_uncertainty_score":0.24891159},"labels":[],"label_agreement":null},{"id":"W2991173142","doi":"10.1002/prp2.519","title":"Evaluation of pharmacokinetics and safety of cetuximab with cisplatin/carboplatin in patients with advanced solid tumor: Result from phase II studies","year":2019,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Eli Lilly and Company","keywords":"Cetuximab; Carboplatin; Cisplatin; Cmax; Pharmacokinetics; Medicine; Pharmacology; Tolerability; Oncology; Internal medicine; Cancer; Adverse effect; Chemotherapy; Colorectal cancer","score_opus":0.05980268489912875,"score_gpt":0.46336174518492923,"score_spread":0.40355906028580046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991173142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882453,0.007295333,7.8524954e-7,0.00037288805,0.000052713367,0.0023132695,0.00012287823,0.000010510655,0.0015863277],"genre_scores_gemma":[0.9982245,0.0012148448,0.00025547785,0.00001866828,0.00003556329,0.00016640362,0.00001914781,0.000019074358,0.000046310535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973838,0.00039893127,0.00033223655,0.00046799515,0.0010910534,0.00032600385],"domain_scores_gemma":[0.9964454,0.00045910565,0.00017327874,0.00015913161,0.0026869643,0.00007609884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009846344,0.00019391703,0.0006753118,0.0002924715,0.00010934372,0.0000033113345,0.00007461087,0.000034503613,0.00021049543],"category_scores_gemma":[0.00022192037,0.00013252582,0.000031132153,0.00045251212,0.0006931867,0.000114419905,0.00014416168,0.00033242235,0.0000010171926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21562177,0.014352545,0.48554033,0.00045825387,0.0090681305,0.000062006104,0.09653561,0.0007290732,0.13053338,0.000070479546,0.0004565647,0.04657185],"study_design_scores_gemma":[0.17003825,0.04052006,0.6876467,0.00056141295,0.0016597409,0.0000039866086,0.035294782,0.0020558145,0.061613902,0.00018991652,0.00010382033,0.000311588],"about_ca_topic_score_codex":0.00008474431,"about_ca_topic_score_gemma":0.00008739019,"teacher_disagreement_score":0.20210637,"about_ca_system_score_codex":0.0004365733,"about_ca_system_score_gemma":0.00030683607,"threshold_uncertainty_score":0.5404246},"labels":[],"label_agreement":null},{"id":"W2996929715","doi":"10.1002/prp2.555","title":"Rituximab utilization for approved and off‐label nononcology indications and patients’ experiences with the Patient Alert Card","year":2020,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Roche","keywords":"Rituximab; Medicine; Progressive multifocal leukoencephalopathy; Microscopic polyangiitis; Granulomatosis with polyangiitis; Retrospective cohort study; Internal medicine; Natalizumab; Pediatrics; Vasculitis; Immunology; Multiple sclerosis; Lymphoma; Disease","score_opus":0.10452317163649866,"score_gpt":0.42040272577368737,"score_spread":0.3158795541371887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996929715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96725875,0.008737682,0.00007355001,0.021638868,0.00003834208,0.0017076288,0.000029257353,0.00003140883,0.0004844843],"genre_scores_gemma":[0.9965442,0.0012873813,0.00012932034,0.00089767674,0.00010399894,0.0009513019,0.000017711012,0.0000147983765,0.00005362169],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9987449,0.00020753052,0.00012458571,0.00039041176,0.00022050612,0.00031207266],"domain_scores_gemma":[0.99884534,0.000368339,0.000054294764,0.000082889754,0.00038911312,0.00026002357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015625093,0.0001148234,0.00021251428,0.00010260032,0.00048562817,0.000023727998,0.00008634857,0.00007525453,0.00006100048],"category_scores_gemma":[0.00021565825,0.00006965631,0.000025246032,0.00026880318,0.0013412257,0.00009043701,0.00009498433,0.00028773726,0.0000031669174],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017098112,0.008252925,0.056568153,0.00041425275,0.0021295894,0.000081159465,0.732147,0.0000068712734,0.02232568,0.0022899262,0.08733429,0.07135206],"study_design_scores_gemma":[0.04203969,0.024038773,0.10447149,0.00008116901,0.001287967,0.00008428171,0.7256664,0.011354208,0.01269407,0.00021335568,0.077341124,0.0007274623],"about_ca_topic_score_codex":0.000019083216,"about_ca_topic_score_gemma":0.000006234057,"teacher_disagreement_score":0.0706246,"about_ca_system_score_codex":0.00005539343,"about_ca_system_score_gemma":0.00022280907,"threshold_uncertainty_score":0.4941802},"labels":[],"label_agreement":null},{"id":"W3032898588","doi":"10.1002/prp2.605","title":"PTH suppression by calcitriol does not predict off‐target actions in experimental CKD","year":2020,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Queen's University","funders":"Queen's University; Canadian Institutes of Health Research; OPKO Health","keywords":"Calcitriol; Endocrinology; Internal medicine; Paricalcitol; Medicine; Calcitriol receptor; Parathyroid hormone; Vitamin D and neurology; Fibroblast growth factor 23; Hyperparathyroidism; Kidney disease; Dosing; Secondary hyperparathyroidism; Calcium","score_opus":0.10013768428662234,"score_gpt":0.4755061568894813,"score_spread":0.37536847260285894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032898588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96119905,0.015736759,0.000011923858,0.016678527,0.00013845401,0.001130723,0.00010769779,0.00008642198,0.004910428],"genre_scores_gemma":[0.9958596,0.00148648,0.00009900302,0.0005356494,0.00025237788,0.0003992957,0.00004745247,0.000029083078,0.0012910367],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975877,0.00042406708,0.00021933959,0.000644283,0.00048107692,0.00064355147],"domain_scores_gemma":[0.999025,0.000205077,0.000038116155,0.00014581962,0.00013840338,0.00044760332],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024076515,0.00020373931,0.0003537823,0.00023440446,0.0002505695,0.000021744336,0.00017418283,0.00011966907,0.001243539],"category_scores_gemma":[0.00016514536,0.00015076935,0.00009916676,0.0004395756,0.0004281232,0.0001963677,0.00015682307,0.0008136285,0.00013219066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027496559,0.0026394257,0.01920258,0.000011032129,0.00021867956,0.00022933562,0.009061357,0.00000601632,0.80439353,0.000044603832,0.16134687,0.00009689586],"study_design_scores_gemma":[0.012530392,0.0019549108,0.012573704,0.000014566927,0.00006310011,0.000019448566,0.026994085,0.0016209973,0.9212414,0.000060492053,0.022695249,0.00023165379],"about_ca_topic_score_codex":0.00015449917,"about_ca_topic_score_gemma":0.000007750617,"teacher_disagreement_score":0.13865161,"about_ca_system_score_codex":0.00036868002,"about_ca_system_score_gemma":0.00022664435,"threshold_uncertainty_score":0.99966943},"labels":[],"label_agreement":null},{"id":"W3045338643","doi":"10.1002/prp2.622","title":"Comparative risk of cardiac arrhythmias associated with acetylcholinesterase inhibitors used in treatment of dementias – A narrative review","year":2020,"lang":"en","type":"review","venue":"Pharmacology Research & Perspectives","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Donepezil; Rivastigmine; Galantamine; Medicine; Torsades de pointes; Dementia; Acetylcholinesterase inhibitor; Bradycardia; Intensive care medicine; Acetylcholinesterase; QT interval; Cardiology; Internal medicine; Disease; Heart rate; Blood pressure","score_opus":0.10312175403246479,"score_gpt":0.4708481431495364,"score_spread":0.36772638911707156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045338643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03772508,0.9549543,4.8705743e-7,0.00044958724,0.00010689173,0.006143237,0.00031570878,0.000029622277,0.00027507334],"genre_scores_gemma":[0.019809248,0.9779352,0.000036274196,0.000021692593,0.00043854536,0.001372883,0.00019510947,0.000060116512,0.00013091131],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98964083,0.006836666,0.0011020515,0.0010242228,0.0006474871,0.00074873166],"domain_scores_gemma":[0.99480915,0.0024910006,0.00096329127,0.0004042286,0.0010608644,0.0002714525],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012002438,0.00070404186,0.007390821,0.0007829429,0.00014118888,0.0000063275893,0.00018680254,0.00036059922,0.00015841181],"category_scores_gemma":[0.0005640565,0.000490758,0.0012238121,0.0023648755,0.0014806732,0.00009505184,0.00011518008,0.0018026084,0.000018642888],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018430721,0.020699782,0.0025284763,0.12574817,0.18331555,0.009735629,0.25218913,0.00006788298,0.0074687256,0.00022963352,0.030717162,0.34886912],"study_design_scores_gemma":[0.023570547,0.03534303,0.0018622238,0.16706048,0.055721257,0.0006497514,0.02824722,0.00003984445,0.009911951,0.000058426154,0.6746662,0.0028690214],"about_ca_topic_score_codex":0.00007403339,"about_ca_topic_score_gemma":0.00003394361,"teacher_disagreement_score":0.6439491,"about_ca_system_score_codex":0.0012476898,"about_ca_system_score_gemma":0.0023428746,"threshold_uncertainty_score":0.9997544},"labels":[],"label_agreement":null},{"id":"W3083842470","doi":"10.1002/prp2.650","title":"Comparing direct acting antivirals for hepatitis C using observational data – Why and how?","year":2020,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Hepatitis C virus research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; HIV Legal Network; University of British Columbia; McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; British Columbia Centre for Disease Control; Provincial Health Services Authority","keywords":"Sofosbuvir; Medicine; Ledipasvir; Hepatitis C; Hepatitis C virus; Internal medicine; Odds ratio; Credible interval; Randomized controlled trial; Confidence interval; Ribavirin; Virology","score_opus":0.7121244435544246,"score_gpt":0.5579325495664182,"score_spread":0.15419189398800637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083842470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9256198,0.0023384676,0.0012600219,0.06388061,0.00010137261,0.0020241062,0.00024291647,0.000114265546,0.004418435],"genre_scores_gemma":[0.9919565,0.0013342655,0.0044343392,0.0009169594,0.000993338,0.00010168304,0.000092260474,0.000050233957,0.0001204497],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9966591,0.00069711247,0.00020103814,0.00091711775,0.00072148937,0.00080413657],"domain_scores_gemma":[0.99659944,0.0017382858,0.00006559733,0.00029756062,0.00086971855,0.00042938345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020430358,0.0001825989,0.0004995878,0.00027496382,0.00056992384,0.0001326949,0.0004239036,0.000094274845,0.00022913153],"category_scores_gemma":[0.004048861,0.0001830983,0.0000579047,0.00061996066,0.0006580153,0.00066857104,0.0008990335,0.00082460913,0.00001183183],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093049003,0.0002344482,0.5877252,0.00042250418,0.000673294,0.00014960098,0.0049904324,0.000014757877,0.32707676,0.0002710415,0.07293879,0.004572657],"study_design_scores_gemma":[0.009143777,0.0016040477,0.08962968,0.00022396752,0.00034853758,0.000044442746,0.010593577,0.62947917,0.041670866,0.00020884356,0.21628074,0.0007723483],"about_ca_topic_score_codex":0.0003738203,"about_ca_topic_score_gemma":0.000071698814,"teacher_disagreement_score":0.6294644,"about_ca_system_score_codex":0.00025026067,"about_ca_system_score_gemma":0.00048172782,"threshold_uncertainty_score":0.74665314},"labels":[],"label_agreement":null},{"id":"W3088561569","doi":"10.1002/prp2.655","title":"The cerebrovascular response to norepinephrine: A scoping systematic review of the animal and human literature","year":2020,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research; National Institutes of Health; Canada Foundation for Innovation; University of Manitoba; Centre County Community Foundation","keywords":"Cerebral blood flow; Medicine; Vasoconstriction; Norepinephrine; Animal studies; Anesthesia; Cochrane Library; Traumatic brain injury; Human studies; Intensive care medicine; Internal medicine; Psychiatry; Meta-analysis","score_opus":0.05358155277368116,"score_gpt":0.4186178896518298,"score_spread":0.3650363368781486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088561569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6583555,0.22644058,0.0000040405534,0.10932933,0.00006048635,0.0053963517,0.000009180173,0.000038594073,0.00036598774],"genre_scores_gemma":[0.9859679,0.010135732,0.00004320259,0.0031305372,0.00015712067,0.00035979843,9.0607375e-7,0.000019488209,0.00018532762],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9956274,0.0026639474,0.0003732275,0.00039877233,0.0006069351,0.00032973784],"domain_scores_gemma":[0.9976386,0.0011585136,0.00009238366,0.00041623527,0.0004943765,0.0001998877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031696493,0.00014964002,0.00055315054,0.00007786544,0.00051829155,0.000042135594,0.00039155534,0.000046254576,0.000060073668],"category_scores_gemma":[0.0045941207,0.00007839923,0.0002115,0.0009150014,0.00063713326,0.0000644876,0.0002776598,0.0006750262,0.000008602324],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036832073,0.0002754324,0.0007912572,0.61526954,0.0015451704,0.00008302585,0.025106637,7.711238e-7,0.33675653,0.0035521789,0.012881958,0.0000542824],"study_design_scores_gemma":[0.0075421273,0.0079771355,0.09632039,0.77598274,0.0029694377,0.00086781546,0.019971844,0.00009860047,0.08129996,0.0002488134,0.0059142425,0.00080689206],"about_ca_topic_score_codex":0.000004430354,"about_ca_topic_score_gemma":0.0000023047555,"teacher_disagreement_score":0.32761243,"about_ca_system_score_codex":0.000051081028,"about_ca_system_score_gemma":0.00015430902,"threshold_uncertainty_score":0.5499923},"labels":[],"label_agreement":null},{"id":"W3089536813","doi":"10.1002/prp2.666","title":"A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?","year":2020,"lang":"en","type":"review","venue":"Pharmacology Research & Perspectives","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Cochrane Library; Confounding; MEDLINE; Internal medicine; Coronavirus disease 2019 (COVID-19); Subgroup analysis; Disease","score_opus":0.5559165868438006,"score_gpt":0.6334286534361528,"score_spread":0.07751206659235221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089536813","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000106838015,0.90619534,0.000012762188,0.08290683,0.000057498277,0.010620737,0.00016094933,0.000030255424,0.00000497016],"genre_scores_gemma":[0.00052694074,0.9923873,0.000048676957,0.005103188,0.000068380556,0.001244098,0.0000033219912,0.000049937422,0.0005681457],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97237885,0.020273013,0.0030027821,0.0015498246,0.0020636043,0.0007319337],"domain_scores_gemma":[0.78774667,0.20505476,0.0017979384,0.00196304,0.0025337066,0.0009038898],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.019830976,0.0006748175,0.015227718,0.000757163,0.00050417666,0.00013394537,0.0012126543,0.00035922357,0.00017059848],"category_scores_gemma":[0.15375455,0.00029643037,0.0051559154,0.0038928487,0.0072139455,0.00026004075,0.0026672734,0.0029791403,0.000012131871],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011386098,0.00016290345,0.00012478823,0.6674423,0.32475892,0.00005859857,0.002566138,5.9225744e-7,8.7273395e-7,0.00010868932,0.002994186,0.0016680914],"study_design_scores_gemma":[0.00043151894,0.00037723195,0.00014104706,0.07399301,0.83224815,0.00002236708,0.0021324386,0.00015406133,5.915522e-7,0.000008933761,0.09025586,0.00023476638],"about_ca_topic_score_codex":0.00040947113,"about_ca_topic_score_gemma":0.000025156007,"teacher_disagreement_score":0.59344935,"about_ca_system_score_codex":0.00058050593,"about_ca_system_score_gemma":0.0030497396,"threshold_uncertainty_score":0.9999488},"labels":[],"label_agreement":null},{"id":"W3090936371","doi":"10.1002/prp2.651","title":"Do proton pump inhibitors increase mortality? A systematic review and in‐depth analysis of the evidence","year":2020,"lang":"en","type":"review","venue":"Pharmacology Research & Perspectives","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Hazard ratio; Randomized controlled trial; MEDLINE; Observational study; Odds ratio; Confidence interval; Systematic review; Internal medicine; Meta-analysis; Relative risk; Intensive care medicine","score_opus":0.18705975992565554,"score_gpt":0.5331258522492109,"score_spread":0.3460660923235554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090936371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033120385,0.9804978,1.6279617e-7,0.00040864822,0.000030288855,0.015527639,0.00004324518,0.000017194143,0.00016299602],"genre_scores_gemma":[0.06784214,0.92783123,0.0000069120256,0.00006178609,0.000053667365,0.0040305266,0.000010668706,0.000032162265,0.00013090995],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9923231,0.0043650055,0.0010125844,0.0008828525,0.0009103559,0.00050609844],"domain_scores_gemma":[0.99684703,0.001258882,0.00048609762,0.0006298283,0.0004504987,0.00032764015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028217116,0.0004298546,0.004852518,0.0010208873,0.00010910276,0.000024729527,0.00045778652,0.0001723707,0.00016850649],"category_scores_gemma":[0.0035223374,0.00023925146,0.0008563934,0.004433335,0.000691305,0.00011331132,0.00048010622,0.0014014796,0.000019687923],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004520491,0.00047099052,0.007263252,0.9768448,0.0124562215,0.0007491784,0.0008346837,1.046091e-7,0.000006330693,0.000015811176,0.000099318175,0.0012141359],"study_design_scores_gemma":[0.0011500057,0.00075757597,0.006004434,0.7538938,0.23521152,0.00017857489,0.0007223805,0.000019999356,0.000043009346,0.000019855132,0.0017175325,0.0002813344],"about_ca_topic_score_codex":0.000121577206,"about_ca_topic_score_gemma":0.000016859152,"teacher_disagreement_score":0.222951,"about_ca_system_score_codex":0.00065516116,"about_ca_system_score_gemma":0.0009209286,"threshold_uncertainty_score":0.97563916},"labels":[],"label_agreement":null},{"id":"W3102018481","doi":"10.1002/prp2.680","title":"Regulatory post‐market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies","year":2020,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Harm; Drug; Business; Medicine; Pharmacology; Risk analysis (engineering); Medical emergency; Actuarial science; Environmental health; Political science; Law","score_opus":0.27701040248965586,"score_gpt":0.5256327882399979,"score_spread":0.24862238575034207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102018481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8969314,0.00483083,0.000011908712,0.023147745,0.0018201055,0.0015851483,0.0010634239,0.00032631998,0.07028313],"genre_scores_gemma":[0.9903224,0.0017315749,0.00007514463,0.0027907449,0.0016588232,0.0002500274,0.00005311901,0.00007007735,0.0030480518],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920176,0.0034872056,0.00081973744,0.0010729905,0.0013939615,0.0012085076],"domain_scores_gemma":[0.9936359,0.0030033612,0.00034462335,0.00030562098,0.0019130037,0.00079747394],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034804514,0.00051115337,0.0009303817,0.0006161389,0.0011783757,0.000034338875,0.0008979707,0.00036212304,0.006563172],"category_scores_gemma":[0.0009912198,0.0005247453,0.00044688315,0.0011375329,0.0023889602,0.0005049364,0.00038012318,0.0034200717,0.00041992374],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006876104,0.0012822232,0.006226006,0.00019947789,0.0016905481,0.000063941145,0.029724462,0.0024725033,0.38428697,0.0070944703,0.55852234,0.0015609674],"study_design_scores_gemma":[0.004906279,0.00084126595,0.019747546,0.000052547704,0.0004289766,0.000015756219,0.045995265,0.006822704,0.33665603,0.0006856632,0.582914,0.0009339418],"about_ca_topic_score_codex":0.000026358655,"about_ca_topic_score_gemma":0.000005344971,"teacher_disagreement_score":0.093391046,"about_ca_system_score_codex":0.0008555583,"about_ca_system_score_gemma":0.0013679812,"threshold_uncertainty_score":0.9997204},"labels":[],"label_agreement":null},{"id":"W3111199989","doi":"10.1002/prp2.687","title":"Classification of drug use patterns","year":2020,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"Research Manitoba","keywords":"Categorical variable; Metformin; Quantile; Medicine; Cluster analysis; Drug; Feature (linguistics); Medical prescription; Statistics; Computer science; Variable (mathematics); Diabetes mellitus; Artificial intelligence; Data mining; Mathematics; Pharmacology","score_opus":0.14745481641764338,"score_gpt":0.42321422220556043,"score_spread":0.275759405787917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111199989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98197156,0.002299524,0.00011734119,0.012661871,0.000086357155,0.0008908643,0.0000279312,0.00007276846,0.0018717812],"genre_scores_gemma":[0.9971333,0.0011056159,0.00016367807,0.00030129458,0.0006711693,0.000111719986,0.000013990931,0.000028680279,0.00047053111],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99764764,0.0006404686,0.00021504407,0.00045677865,0.0006226287,0.00041746302],"domain_scores_gemma":[0.9983558,0.0002821975,0.000054494307,0.00025424073,0.0007273748,0.00032587867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009096733,0.00012475856,0.0004032853,0.00021854829,0.00010445958,0.000020921862,0.00018931949,0.00007606211,0.0008176272],"category_scores_gemma":[0.000646716,0.000113338465,0.00023083558,0.00045669748,0.00048781993,0.00017494013,0.00011276165,0.00071597315,0.000104526676],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035798664,0.002597161,0.15650493,0.0011889619,0.0045856875,0.0003806472,0.071635276,0.000026658805,0.57937,0.0017636192,0.09554884,0.08281836],"study_design_scores_gemma":[0.0039149136,0.0007922572,0.8308517,0.000057366666,0.00033044253,0.000016400361,0.021408321,0.0008012241,0.10941897,0.00009914796,0.032086115,0.00022318501],"about_ca_topic_score_codex":0.0012218157,"about_ca_topic_score_gemma":0.00004474693,"teacher_disagreement_score":0.67434675,"about_ca_system_score_codex":0.000118018135,"about_ca_system_score_gemma":0.00019681323,"threshold_uncertainty_score":0.8952444},"labels":[],"label_agreement":null},{"id":"W3120043760","doi":"10.1002/prp2.707","title":"Tyrosine kinase inhibitors targeting vascular endothelial growth factor and the risk of aortic dissection—A pharmacovigilance analysis","year":2021,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Aortic dissection; Blood pressure; Internal medicine; Cardiology; Pharmacovigilance; Odds ratio; Risk factor; Adverse effect; Aorta","score_opus":0.019202630278666047,"score_gpt":0.352676969428183,"score_spread":0.33347433914951696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120043760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9380742,0.059596613,0.00024999233,0.0011001662,0.00012572481,0.00051027833,0.000070895396,0.00004008879,0.00023203863],"genre_scores_gemma":[0.95918,0.039878603,0.00006481782,0.00008231844,0.0005244119,0.00008520117,0.000016260106,0.000023498562,0.00014491101],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99597573,0.002037737,0.00030854632,0.00055314763,0.0006695572,0.0004552641],"domain_scores_gemma":[0.9974552,0.0009856585,0.00010440937,0.0002566773,0.0009868578,0.00021121415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001573901,0.00019530903,0.00067850633,0.00032941048,0.0005186692,0.000033343953,0.00013695992,0.000075846525,0.00081963214],"category_scores_gemma":[0.0011479728,0.00013569793,0.000807632,0.0014686238,0.0014046048,0.00012193939,0.00013238698,0.0007207405,0.0000061584137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007439401,0.0015758948,0.33776432,0.00036843194,0.050525077,0.00059106696,0.011692558,0.00013970435,0.5838627,0.00077083224,0.0012859786,0.0039840224],"study_design_scores_gemma":[0.023540474,0.00038842336,0.19629394,0.00006708668,0.0150083555,0.00010488405,0.019139947,0.0031518347,0.73850775,0.00062790094,0.002682383,0.0004870488],"about_ca_topic_score_codex":0.00013852392,"about_ca_topic_score_gemma":0.00000633828,"teacher_disagreement_score":0.15464503,"about_ca_system_score_codex":0.00009083931,"about_ca_system_score_gemma":0.0002201265,"threshold_uncertainty_score":0.8974397},"labels":[],"label_agreement":null},{"id":"W3147918177","doi":"10.1002/prp2.758","title":"Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of lemborexant","year":2021,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eisai","keywords":"Cmax; Tolerability; Pharmacokinetics; Medicine; Dosing; Adverse effect; Internal medicine; Gastroenterology","score_opus":0.053753072690394914,"score_gpt":0.4452083302812825,"score_spread":0.39145525759088756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3147918177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99219644,0.0010599992,0.000013254352,0.0017972433,0.0001631691,0.0008720736,0.000057901292,0.000023851375,0.0038160589],"genre_scores_gemma":[0.9970743,0.002457454,0.000015672063,0.000055601064,0.00009106433,0.00009317364,0.0000016142186,0.00002036187,0.00019077663],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9920406,0.0050985594,0.00039415754,0.00078973145,0.0010078908,0.0006690907],"domain_scores_gemma":[0.99241716,0.006389647,0.000087984336,0.00033289337,0.00054502446,0.00022731873],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031233004,0.00019499965,0.0005465371,0.00036046148,0.00023001569,0.000021776485,0.00038258848,0.00007560036,0.0012424719],"category_scores_gemma":[0.0027158293,0.00016048572,0.00011376114,0.00085564324,0.0019608606,0.000100165795,0.00050038844,0.0007778727,0.000017170165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039781258,0.0014145144,0.0055030202,0.00039782526,0.00008872916,0.00013951136,0.0021123476,0.000054753742,0.9758134,0.0013192336,0.0004619372,0.008716635],"study_design_scores_gemma":[0.002531507,0.0030475277,0.0048851143,0.000034637527,0.000034213674,0.0000193961,0.00057569,0.0010297535,0.98707914,0.00031198075,0.00033504976,0.00011599263],"about_ca_topic_score_codex":0.000053320982,"about_ca_topic_score_gemma":0.0000040455348,"teacher_disagreement_score":0.0112657705,"about_ca_system_score_codex":0.00018081267,"about_ca_system_score_gemma":0.00024311623,"threshold_uncertainty_score":0.9996705},"labels":[],"label_agreement":null},{"id":"W3161839669","doi":"10.1002/prp2.781","title":"Prevalence and determinants of attention deficit/hyperactivity disorder (ADHD) medication use during pregnancy: Results from the Quebec Pregnancy/Children Cohort","year":2021,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Pregnancy; Attention deficit hyperactivity disorder; Odds ratio; Methylphenidate; Cohort; Psychiatry; Population; Mood; Cohort study; Anxiety; Confidence interval; Medical prescription; Pediatrics; Internal medicine","score_opus":0.054046090258047325,"score_gpt":0.40584789813608246,"score_spread":0.35180180787803517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161839669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97677946,0.019242024,0.0000053214603,0.002057656,0.00019397875,0.0013826621,0.00021423957,0.000033969372,0.0000906792],"genre_scores_gemma":[0.97876894,0.018534197,0.00009138775,0.00001966571,0.00015513088,0.000192299,0.000040286115,0.000021996262,0.0021761179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673355,0.0010779373,0.00042542984,0.0007059255,0.00057919236,0.0004779691],"domain_scores_gemma":[0.9976262,0.0011584782,0.00019127918,0.00041711927,0.00042755742,0.00017935551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005329012,0.00018047346,0.00033460325,0.000099518234,0.00040348002,0.000033483047,0.00017992812,0.0001192811,0.00017207148],"category_scores_gemma":[0.0007643991,0.00014067267,0.000069512,0.00022965587,0.0006279877,0.00036368045,0.00025758962,0.0006675733,0.0000113594315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011913745,0.00056216086,0.9803146,0.0009827635,0.00017240125,0.00011265332,0.0023206756,9.411739e-7,0.0130893495,0.000020303429,0.000026388561,0.0012064031],"study_design_scores_gemma":[0.002460857,0.00015393936,0.973274,0.006035916,0.0001613494,0.00012405122,0.0008030427,0.000078882964,0.016746784,0.000038193062,0.000009547296,0.00011346392],"about_ca_topic_score_codex":0.0060403226,"about_ca_topic_score_gemma":0.0010022662,"teacher_disagreement_score":0.007040612,"about_ca_system_score_codex":0.00017394936,"about_ca_system_score_gemma":0.00029252205,"threshold_uncertainty_score":0.9131201},"labels":[],"label_agreement":null},{"id":"W3163833951","doi":"10.1002/prp2.775","title":"The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs","year":2021,"lang":"en","type":"review","venue":"Pharmacology Research & Perspectives","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Nova Scotia Health Authority; Dalhousie University","funders":"Canadian Institutes of Health Research; Dalhousie University; Nova Scotia Health Research Foundation; Consortium canadien en neurodégénérescence associée au vieillissement","keywords":"Anticholinergic; CYP2D6; Medicine; Pharmacokinetics; Pharmacology; Adverse effect; Drug; CYP2C19; Population; Drug metabolism; Internal medicine; Cytochrome P450; Metabolism","score_opus":0.18636445799063292,"score_gpt":0.5187489279675305,"score_spread":0.3323844699768975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163833951","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021203812,0.9706887,0.0000016983284,0.0005368154,0.00087036146,0.0020885027,0.00048294637,0.000025253099,0.004101911],"genre_scores_gemma":[0.08916319,0.9087233,0.00005755695,0.000130374,0.00071957806,0.0003640623,0.000020188614,0.00011355556,0.00070817146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.985821,0.009144663,0.0016763571,0.0010240132,0.0010407071,0.0012932733],"domain_scores_gemma":[0.9853838,0.011295669,0.0010802614,0.00077487365,0.0010584032,0.0004069949],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0044594253,0.0008311572,0.0026260295,0.00073654164,0.00071490253,0.00004263356,0.0020137925,0.00067055406,0.0010099073],"category_scores_gemma":[0.0004434761,0.00053378445,0.00082286977,0.0014704886,0.0059642233,0.00005778281,0.0011190491,0.0038659195,0.000018448327],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006049218,0.0023037312,0.000080479665,0.0032135365,0.0069917184,0.00025701447,0.009197386,0.00007211362,0.06940637,0.016383655,0.0068586776,0.8846304],"study_design_scores_gemma":[0.0012793913,0.0002958143,0.000024040106,0.0005041152,0.002575494,0.00006424673,0.0031651917,0.00028542904,0.10443048,0.00062394526,0.88631785,0.00043402385],"about_ca_topic_score_codex":0.000046322326,"about_ca_topic_score_gemma":0.0000031159655,"teacher_disagreement_score":0.8841964,"about_ca_system_score_codex":0.00011348339,"about_ca_system_score_gemma":0.000999813,"threshold_uncertainty_score":0.9999033},"labels":[],"label_agreement":null},{"id":"W3164448554","doi":"10.1002/prp2.794","title":"Exploring the Food and Drug Administration’s review and approval of Entresto (sacubitril/valsartan)","year":2021,"lang":"en","type":"review","venue":"Pharmacology Research & Perspectives","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Food and drug administration; Regulatory science; Sacubitril, Valsartan; Valsartan; Agency (philosophy); Medicine; Drug development; Business; Strengths and weaknesses; Pharmacology; Sacubitril; Drug; Psychology","score_opus":0.4617126359250331,"score_gpt":0.4775476366956166,"score_spread":0.01583500077058353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164448554","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005079068,0.98864174,0.000002045123,0.0059716096,0.00020057884,0.0012982772,0.000392305,0.000012499227,0.002973045],"genre_scores_gemma":[0.0024915412,0.9956887,0.000031189233,0.0002705331,0.00035146723,0.0007025367,0.00001589849,0.00004413116,0.00040405223],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970224,0.00054839184,0.00094234606,0.0008527405,0.000075182164,0.0005589585],"domain_scores_gemma":[0.99758244,0.0012791657,0.0004080177,0.00034738792,0.00014476787,0.00023821736],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028658297,0.00033097915,0.0023749445,0.00037949797,0.00026901544,0.000094693954,0.00045839674,0.000104753475,0.0005065912],"category_scores_gemma":[0.0004626137,0.0002867689,0.00028701036,0.0005269504,0.0008322285,0.00024583424,0.00046508506,0.0011722351,0.000052216146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005531552,0.00085456204,0.00008158404,0.06911215,0.004108433,0.00004992698,0.0060676895,6.441555e-7,0.0000070031406,0.6078665,0.039510995,0.27228516],"study_design_scores_gemma":[0.00025173623,0.00010564565,0.000012417182,0.0011526404,0.0003377633,0.000048271155,0.00040084563,0.000009622301,0.000018308381,0.0015838776,0.9958119,0.00026701836],"about_ca_topic_score_codex":0.000030988664,"about_ca_topic_score_gemma":0.000012085507,"teacher_disagreement_score":0.95630085,"about_ca_system_score_codex":0.00018654426,"about_ca_system_score_gemma":0.00033626298,"threshold_uncertainty_score":0.99995846},"labels":[],"label_agreement":null},{"id":"W3183541999","doi":"10.1002/prp2.833","title":"Answering questions in a co‐created formative exam question bank improves summative exam performance, while students perceive benefits from answering, authoring, and peer discussion: A mixed methods analysis of PeerWise","year":2021,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Student Assessment and Feedback","field":"Social Sciences","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Summative assessment; Formative assessment; Test (biology); Medical education; Multiple choice; Peer assessment; Class (philosophy); Psychology; Mathematics education; Computer science; Medicine; Internal medicine; Artificial intelligence","score_opus":0.0832141660436603,"score_gpt":0.5168632575806068,"score_spread":0.43364909153694653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183541999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99211705,0.0013074315,0.00019576619,0.0014006322,0.00024382795,0.00073829654,0.000075368516,0.00006795088,0.003853651],"genre_scores_gemma":[0.9927993,0.003471605,0.001741119,0.000015158374,0.0001575563,0.00027010962,0.00007017438,0.000021234271,0.0014537594],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99229234,0.0042742086,0.0005018188,0.0007823506,0.0013719415,0.0007773353],"domain_scores_gemma":[0.9965599,0.0013258172,0.00019306273,0.0002202748,0.0014263812,0.00027454694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057008625,0.0002800191,0.0007134087,0.0012043276,0.00095760403,0.0002058151,0.0005012124,0.00019998128,0.00082599715],"category_scores_gemma":[0.0008119964,0.00023983567,0.00015245612,0.0029388107,0.0010857829,0.0010454712,0.0004544411,0.0008204043,0.0000064772007],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000354689,0.0010560368,0.4154256,0.000041875443,0.0023467115,0.000028856326,0.5476269,0.00029234475,0.025746386,0.0014534341,0.00043051745,0.005196645],"study_design_scores_gemma":[0.000914013,0.00017249714,0.720435,0.00007424169,0.00040754245,5.8365373e-7,0.27103013,0.0025525421,0.0036965194,0.00013313514,0.00036310495,0.00022067719],"about_ca_topic_score_codex":0.0032227624,"about_ca_topic_score_gemma":0.0042103096,"teacher_disagreement_score":0.30500942,"about_ca_system_score_codex":0.0006623521,"about_ca_system_score_gemma":0.00036538293,"threshold_uncertainty_score":0.9780215},"labels":[],"label_agreement":null},{"id":"W3190167208","doi":"10.1002/prp2.848","title":"Use of levothyroxine among pregnant women with subclinical hypothyroidism in the United Kingdom: A population‐based assessment","year":2021,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Thyroid Disorders and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Levothyroxine; Medicine; Medical prescription; Pregnancy; Interquartile range; Pediatrics; Obstetrics; Subclinical infection; Population; Gestational diabetes; Reproductive medicine; Gynecology; Internal medicine; Gestation; Thyroid","score_opus":0.20059650217703276,"score_gpt":0.47564877869401234,"score_spread":0.2750522765169796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190167208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929444,0.00059560954,0.000048780817,0.005057757,0.00003267603,0.0009756838,0.000015932947,0.00002390919,0.00030522526],"genre_scores_gemma":[0.99800515,0.00021279971,0.00069953606,0.00026941366,0.000054475906,0.00039299994,0.00005766311,0.000026373922,0.00028156425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965762,0.0014032713,0.00032497355,0.00048517325,0.0006212477,0.00058915425],"domain_scores_gemma":[0.9973173,0.0014726868,0.000093800765,0.00036086643,0.00059061375,0.00016473244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009966104,0.00017814677,0.0004184928,0.00051949656,0.00016242401,0.000035329358,0.00016751797,0.000090980924,0.0003407398],"category_scores_gemma":[0.00039879122,0.000113214955,0.000074621785,0.0015191572,0.0005710343,0.00014315019,0.000083048966,0.00079134415,0.000003984823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028635177,0.008149954,0.964529,0.00006352076,0.00062768976,0.0013072065,0.0054185684,0.0003142493,0.013672495,0.0019813827,0.0008966558,0.00017580805],"study_design_scores_gemma":[0.007551165,0.0017284086,0.9800722,0.000077207114,0.00010358634,0.000026507012,0.0074873664,0.0009357531,0.0013314441,0.00030030773,0.00026916867,0.00011689121],"about_ca_topic_score_codex":0.0013337675,"about_ca_topic_score_gemma":0.00030867234,"teacher_disagreement_score":0.015543243,"about_ca_system_score_codex":0.00044481352,"about_ca_system_score_gemma":0.00062061055,"threshold_uncertainty_score":0.4616772},"labels":[],"label_agreement":null},{"id":"W3203941551","doi":"10.1002/prp2.846","title":"Bioequivalence and food effect of a fixed‐dose combination of macitentan and tadalafil: Adaptive design in the COVID‐19 pandemic","year":2021,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Actelion Pharmaceuticals","keywords":"Bioequivalence; Tadalafil; Medicine; Pharmacology; Pharmacokinetics; Adverse effect; Crossover study; Confidence interval; Bioavailability; Dosing; Coronavirus disease 2019 (COVID-19); Fixed-dose combination; Internal medicine; Sildenafil","score_opus":0.17539696102265348,"score_gpt":0.4501615824634102,"score_spread":0.27476462144075675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203941551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97817457,0.018240152,0.00013948423,0.002241171,0.00003182452,0.0009397421,0.000016279479,0.000013333858,0.00020345554],"genre_scores_gemma":[0.99644035,0.0031188591,0.000114061186,0.00010400552,0.000037659996,0.00007928858,0.0000054526795,0.000010234587,0.00009008737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700546,0.001803131,0.00022132361,0.00033965678,0.00035283813,0.0002775603],"domain_scores_gemma":[0.995976,0.0033797272,0.00007717304,0.00013018576,0.00030544144,0.00013151375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024625799,0.00012293854,0.00034336073,0.00028727044,0.00012020135,0.000011590881,0.00010289329,0.000078170764,0.00010243664],"category_scores_gemma":[0.00096015574,0.00009226083,0.000050832616,0.0005609147,0.001090999,0.00010443761,0.000092470924,0.00033190858,7.1803476e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041482137,0.000923393,0.6612808,0.00061379274,0.00044424576,0.00014993075,0.04189926,0.00001682704,0.2797141,0.0059704124,0.0008220337,0.004016974],"study_design_scores_gemma":[0.020680223,0.014277784,0.76837146,0.00022641403,0.00045673086,0.0008397493,0.038192514,0.003907212,0.14584865,0.0066581606,0.0002200799,0.0003210489],"about_ca_topic_score_codex":0.00012236158,"about_ca_topic_score_gemma":0.000039194383,"teacher_disagreement_score":0.13386545,"about_ca_system_score_codex":0.00011283415,"about_ca_system_score_gemma":0.0003147109,"threshold_uncertainty_score":0.4019831},"labels":[],"label_agreement":null},{"id":"W3209909776","doi":"10.1002/prp2.886","title":"Jadomycins: A potential chemotherapy for multi‐drug resistant metastatic breast cancer","year":2021,"lang":"en","type":"review","venue":"Pharmacology Research & Perspectives","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Dalhousie University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Breast cancer; Metastatic breast cancer; Medicine; Doxorubicin; Cancer; Paclitaxel; Chemotherapy; Drug resistance; Oncology; Pharmacology; Cancer research; Drug; Internal medicine; Cancer cell; Efflux; ATP-binding cassette transporter; Transporter; Biology; Microbiology","score_opus":0.14206483091366462,"score_gpt":0.5151833281982382,"score_spread":0.3731184972845736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209909776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000086661545,0.99358255,0.00073730986,0.00078413024,0.0007177849,0.0025503358,0.0014661514,0.000022202215,0.00005285065],"genre_scores_gemma":[0.00020634348,0.9884345,0.0011256807,0.0002111774,0.0019361404,0.0035944723,0.0002785874,0.00018140158,0.0040316912],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99570936,0.0010140749,0.00047043274,0.0013876322,0.00038586947,0.0010326267],"domain_scores_gemma":[0.997896,0.00011795031,0.00022153856,0.00048823963,0.0010268255,0.00024942032],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011898475,0.0005616459,0.0013394563,0.00030766166,0.00039344496,0.000093853276,0.0006916413,0.0003009196,0.0006360871],"category_scores_gemma":[0.000047937858,0.0004972689,0.00090524857,0.00040910143,0.00042701434,0.000007618209,0.0003086437,0.0007459708,0.000010898843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019265102,0.002191087,7.24045e-7,0.008744794,0.012305849,0.00015165581,0.001369206,0.000009841209,0.15671457,0.00088923896,0.053918283,0.76177824],"study_design_scores_gemma":[0.002225425,0.00026465434,0.0000011583717,0.0007048597,0.00094158185,0.000099791185,0.0011671106,0.000038880025,0.0039414368,0.000053719294,0.9900361,0.0005253067],"about_ca_topic_score_codex":0.00010678217,"about_ca_topic_score_gemma":0.000101164835,"teacher_disagreement_score":0.93611777,"about_ca_system_score_codex":0.00039418472,"about_ca_system_score_gemma":0.0022270717,"threshold_uncertainty_score":0.9997479},"labels":[],"label_agreement":null},{"id":"W4210453303","doi":"10.1002/prp2.915","title":"Impact of schizophrenia relapse definition on the comparative effectiveness of oral versus injectable antipsychotics: A systematic review and meta‐analysis of observational studies","year":2022,"lang":"en","type":"review","venue":"Pharmacology Research & Perspectives","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Observational study; Medicine; Schizophrenia (object-oriented programming); MEDLINE; Statistic; Meta-analysis; Systematic review; Psychiatry; Internal medicine; Statistics","score_opus":0.6334984890362099,"score_gpt":0.5888448286106728,"score_spread":0.04465366042553709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210453303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007123615,0.98498404,5.780942e-7,0.0001485056,0.000034872297,0.006949961,0.0006211126,0.000010524249,0.0001267848],"genre_scores_gemma":[0.03300643,0.96365,0.00010635832,0.0000066451453,0.000013254397,0.0030345693,0.00013544342,0.000027081815,0.00002023786],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9863238,0.010504901,0.00096427934,0.00062484224,0.0011690921,0.00041308464],"domain_scores_gemma":[0.97200054,0.024991702,0.0007664084,0.0005538325,0.0015464108,0.00014112469],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0059371265,0.00046288822,0.008874471,0.0015616145,0.00022480014,0.000009935979,0.00035932622,0.00010582053,0.0009490341],"category_scores_gemma":[0.002458132,0.00024602484,0.0022548586,0.0037123894,0.0013189341,0.000080351885,0.00025964715,0.0011374074,0.0000052680944],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014835825,0.0012964832,0.000021309035,0.37304986,0.6060296,0.000021652053,0.000585089,0.000006541267,0.00001331787,0.0038834931,0.00018492356,0.00007188439],"study_design_scores_gemma":[0.003678452,0.0067122257,0.0007953748,0.024900299,0.96145725,0.000026378904,0.001697698,0.000018243622,0.000042000866,0.00037420666,0.00006396299,0.00023392179],"about_ca_topic_score_codex":0.00007103239,"about_ca_topic_score_gemma":0.000016898684,"teacher_disagreement_score":0.35542762,"about_ca_system_score_codex":0.0007659572,"about_ca_system_score_gemma":0.0013680283,"threshold_uncertainty_score":0.9999992},"labels":[],"label_agreement":null},{"id":"W4223517548","doi":"10.1002/prp2.949","title":"Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy","year":2022,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Resverlogix (Canada)","funders":"","keywords":"Inflammation; Enzyme replacement therapy; Innate immune system; Immune system; Chemokine; Oxidative stress; Peripheral blood mononuclear cell; Globotriaosylceramide; Immunology; Medicine; Biology; Endocrinology; Disease; Internal medicine; Biochemistry","score_opus":0.030653899441119962,"score_gpt":0.35002483310641136,"score_spread":0.3193709336652914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223517548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891837,0.0035961184,0.000029144827,0.002759217,0.00010153563,0.0038910299,0.0001613387,0.000042414315,0.00023545056],"genre_scores_gemma":[0.99622345,0.0011872968,0.00003195901,0.00007850929,0.00006937002,0.001631061,0.0004038826,0.000052520438,0.0003219425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99444604,0.0020613533,0.00053423626,0.0007177998,0.001534653,0.0007059117],"domain_scores_gemma":[0.99820936,0.00033968032,0.0001917113,0.00033519257,0.00069433404,0.00022972045],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015108208,0.0002271788,0.00041731744,0.00080625265,0.000334653,0.00002378486,0.0002596041,0.000083090425,0.0023792074],"category_scores_gemma":[0.000319774,0.00023236396,0.00009632835,0.0011679212,0.0004913785,0.00024360554,0.00037480117,0.0012902957,0.000017052822],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013838612,0.0029025655,0.021847107,0.00008146172,0.00026384107,0.000058876136,0.010136641,0.00009329394,0.94705045,0.0000048099278,0.0017449405,0.0019774153],"study_design_scores_gemma":[0.012117602,0.002361277,0.09271748,0.00009003834,0.000033561635,0.0000010933927,0.010910277,0.00069506734,0.87990713,0.00015022844,0.000760652,0.00025556982],"about_ca_topic_score_codex":0.0011621237,"about_ca_topic_score_gemma":0.00002353326,"teacher_disagreement_score":0.07087038,"about_ca_system_score_codex":0.0017248215,"about_ca_system_score_gemma":0.0004327612,"threshold_uncertainty_score":0.9985328},"labels":[],"label_agreement":null},{"id":"W4224314217","doi":"10.1002/prp2.950","title":"Impact of the mouse estrus cycle on cannabinoid receptor agonist‐induced molecular and behavioral outcomes","year":2022,"lang":"en","type":"review","venue":"Pharmacology Research & Perspectives","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Saskatchewan","funders":"Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan","keywords":"Cannabinoid; Cannabinoid receptor; Agonist; Estrous cycle; Catalepsy; Cannabinoid receptor antagonist; Endocannabinoid system; Cannabinoid receptor type 2; Pharmacology; Endocrinology; Receptor; Internal medicine; Cannabinoid Receptor Agonists; Medicine","score_opus":0.12439241948357556,"score_gpt":0.5157720996614127,"score_spread":0.39137968017783714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224314217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28277594,0.7079735,6.114745e-8,0.002746974,0.00019668597,0.004986069,0.0004034492,0.000043492837,0.00087386055],"genre_scores_gemma":[0.016098838,0.9716218,0.000008710869,0.000056109293,0.00022896446,0.0028336898,0.00006455699,0.00017910713,0.008908211],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99285334,0.0025182154,0.0006091396,0.0011141538,0.0016706074,0.0012345313],"domain_scores_gemma":[0.9974913,0.00021502479,0.00026575918,0.000921461,0.0005343142,0.00057214213],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015317252,0.0006302334,0.0020535386,0.0010196258,0.0006837789,0.000063871215,0.0008858079,0.00035649835,0.0043836148],"category_scores_gemma":[0.0005123653,0.000395623,0.0014729887,0.0013250338,0.0015086455,0.0000686332,0.0010865355,0.0044203233,0.000026144793],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028843167,0.012402385,0.0026230956,0.013171125,0.007994459,0.0011836615,0.007483678,0.000010417483,0.036274448,0.0010071384,0.24849488,0.6664704],"study_design_scores_gemma":[0.0029433966,0.0072337817,0.0025713798,0.0006786279,0.0013747391,0.00025786285,0.0025024714,0.0000059804124,0.0019531233,0.000037446032,0.97970587,0.0007353491],"about_ca_topic_score_codex":0.0015262912,"about_ca_topic_score_gemma":0.000016718872,"teacher_disagreement_score":0.73121095,"about_ca_system_score_codex":0.0025550898,"about_ca_system_score_gemma":0.0042458097,"threshold_uncertainty_score":0.99984956},"labels":[],"label_agreement":null},{"id":"W4281630979","doi":"10.1002/prp2.975","title":"Involvement of β‐adrenoceptors in the cardiovascular responses induced by selective adenosine A <sub>2A</sub> and A <sub>2B</sub> receptor agonists","year":2022,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Medical Research Council Canada; British Heart Foundation","keywords":"Adenosine; Pharmacology; Medicine; Adrenergic receptor; Adenosine receptor; Receptor; Agonist; Neuroscience; Internal medicine; Psychology","score_opus":0.03496740058660548,"score_gpt":0.33561360304356846,"score_spread":0.300646202456963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281630979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95524335,0.04209699,0.000017345685,0.0013810614,0.00010238955,0.0009191747,0.00008596588,0.00001374471,0.00013996873],"genre_scores_gemma":[0.9946091,0.0039338856,0.000020209229,0.00021674845,0.0003056871,0.00074927934,0.00007152558,0.000041338728,0.000052233827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9941564,0.0032241056,0.00033777856,0.00084454677,0.00074355025,0.0006936109],"domain_scores_gemma":[0.9987005,0.00033501003,0.00011147315,0.00035533163,0.0003719047,0.00012580022],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030977179,0.00027516557,0.00040005622,0.00036005312,0.0005636422,0.000031965774,0.0005489913,0.00014406952,0.000066890294],"category_scores_gemma":[0.00031010728,0.00024961802,0.00019807159,0.00087518495,0.00058010867,0.000016808392,0.0006370907,0.00097588485,0.000003300268],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001537748,0.00053507806,0.00069755636,0.000032512206,0.00072878617,0.000027618553,0.0062474916,0.00007802786,0.9416782,0.000038882743,0.04791202,0.00048608065],"study_design_scores_gemma":[0.0017310573,0.001614233,0.0012548281,0.000009937186,0.00007517114,0.00003870301,0.0144713335,0.000019706027,0.9738008,0.00007316011,0.00665507,0.00025603827],"about_ca_topic_score_codex":0.00016161009,"about_ca_topic_score_gemma":0.000015735834,"teacher_disagreement_score":0.04125695,"about_ca_system_score_codex":0.00021189234,"about_ca_system_score_gemma":0.00041009602,"threshold_uncertainty_score":0.9999956},"labels":[],"label_agreement":null},{"id":"W4289885426","doi":"10.1002/prp2.993","title":"Characterization of <scp>TR</scp> ‐107, a novel chemical activator of the human mitochondrial protease <scp>ClpP</scp>","year":2022,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"In vivo; TFAM; Pharmacology; Chemistry; In vitro; Potency; Protease; Activator (genetics); Biochemistry; Biology; Cancer research; Mitochondrion; Enzyme; Receptor; Mitochondrial biogenesis","score_opus":0.0390675313313631,"score_gpt":0.3708474548638798,"score_spread":0.33177992353251673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289885426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962627,0.00042466974,0.00007420573,0.0003860916,0.00021007913,0.0014704795,0.00037483656,0.000015339147,0.00078158104],"genre_scores_gemma":[0.99571824,0.00011320272,0.0000672758,0.000062090585,0.00089238834,0.0007846581,0.00015228319,0.000049749713,0.0021601308],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962134,0.0010242979,0.00036856788,0.00071006594,0.0009358886,0.00074781897],"domain_scores_gemma":[0.9981074,0.00033421087,0.00023252972,0.0004901251,0.000641259,0.00019451055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084642146,0.00022607182,0.0003306337,0.00022908468,0.00058980583,0.00002322383,0.0010363125,0.00017194927,0.00021180692],"category_scores_gemma":[0.0014405344,0.00020072474,0.0002473128,0.00067818194,0.0011555287,0.000019712279,0.0015267602,0.0009982571,0.000006765564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013955047,0.0013900723,0.0010699672,0.00006478425,0.0003131206,0.000007154499,0.0016233954,0.000010817596,0.9883665,0.00019881528,0.0067501534,0.00006569065],"study_design_scores_gemma":[0.0015573959,0.0005535512,0.0015284263,0.00001080729,0.000036023615,0.0000078140465,0.0036901094,0.00006140963,0.97088486,0.000057321562,0.021562941,0.000049347786],"about_ca_topic_score_codex":0.000055529756,"about_ca_topic_score_gemma":0.0000022431532,"teacher_disagreement_score":0.017481627,"about_ca_system_score_codex":0.00014567745,"about_ca_system_score_gemma":0.0006605001,"threshold_uncertainty_score":0.8185317},"labels":[],"label_agreement":null},{"id":"W4293312764","doi":"10.1002/prp2.999","title":"Fatty acid amide hydrolase inhibition and N‐arachidonoylethanolamine modulation by isoflavonoids: A novel target for upcoming antidepressants","year":2022,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute on Drug Abuse; Higher Education Commision, Pakistan","keywords":"Fatty acid amide hydrolase; Endocannabinoid system; Behavioural despair test; Anandamide; Pharmacology; Genistein; Chemistry; Isoflavones; Cannabinoid receptor; Biochemistry; Internal medicine; Medicine; Antidepressant; Hippocampus; Receptor; Agonist","score_opus":0.04268050282405988,"score_gpt":0.3904483515101397,"score_spread":0.3477678486860798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293312764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9630571,0.004314649,0.0018272531,0.027122157,0.00012375598,0.002555135,0.0003960544,0.00008263851,0.00052125624],"genre_scores_gemma":[0.9928892,0.0003934917,0.0005547933,0.00028885226,0.00035432595,0.002262948,0.00014328289,0.000062974745,0.0030501117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99648964,0.00042904294,0.00032117136,0.00089262513,0.0009246842,0.0009428491],"domain_scores_gemma":[0.99852604,0.00017768837,0.00009143436,0.00024396878,0.00061809714,0.00034278052],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0024153248,0.00023607472,0.00041772934,0.0006968887,0.0015481574,0.00006324538,0.0001781434,0.000111402245,0.00089765404],"category_scores_gemma":[0.0004235835,0.00024276973,0.00013224856,0.0006175835,0.000617661,0.00026225418,0.0004985977,0.0013856272,0.0000049616265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026142418,0.001165868,0.0022323579,0.00015112747,0.00017059759,0.00003993639,0.0021435504,0.00008091646,0.9189739,0.00022119413,0.07131079,0.00089551695],"study_design_scores_gemma":[0.016414806,0.004498553,0.019029802,0.00004332858,0.00013364917,0.00029420978,0.011362244,0.042856093,0.8424126,0.00084583135,0.06152002,0.0005888826],"about_ca_topic_score_codex":0.0001662255,"about_ca_topic_score_gemma":0.000010467438,"teacher_disagreement_score":0.076561324,"about_ca_system_score_codex":0.0006760486,"about_ca_system_score_gemma":0.0003018949,"threshold_uncertainty_score":0.9997517},"labels":[],"label_agreement":null},{"id":"W4294719133","doi":"10.1002/prp2.995","title":"Correlation of functional and radioligand binding characteristics of <scp>GPER</scp> ligands confirming aldosterone as a <scp>GPER</scp> agonist","year":2022,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Robarts Clinical Trials","funders":"Heart and Stroke Foundation of Canada","keywords":"GPER; Aldosterone; Receptor; Agonist; Mineralocorticoid receptor; Mineralocorticoid; Endocrinology; Biology; Chemistry; Internal medicine; Estrogen receptor; Biochemistry; Medicine","score_opus":0.02266931933385348,"score_gpt":0.32683826937280397,"score_spread":0.3041689500389505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294719133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901135,0.0069934544,0.00005900849,0.00015343651,0.00036227875,0.0005357678,0.00011041796,0.000017977281,0.0016541344],"genre_scores_gemma":[0.9948757,0.0019426652,0.000039224975,0.000045689965,0.00030107432,0.00012144581,0.00019799531,0.00004069726,0.002435497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99747247,0.0005148135,0.0003750606,0.0005928192,0.0004753277,0.0005694852],"domain_scores_gemma":[0.99833035,0.00061744085,0.00024650682,0.00020557595,0.00040513685,0.00019500675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012247292,0.00023606527,0.0003926421,0.00036093243,0.00063628604,0.000029666764,0.00025243367,0.00022423474,0.000069143076],"category_scores_gemma":[0.00064374733,0.00024384793,0.00012345953,0.0003882469,0.0008693118,0.000020086676,0.00048672108,0.00085373275,0.000008568977],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002282396,0.00035642777,0.00857196,0.00006926596,0.00052633975,0.000034399018,0.0037119687,0.000111830544,0.9805003,0.0002921996,0.0053462824,0.00025081314],"study_design_scores_gemma":[0.0032008712,0.0032959348,0.010811829,0.00003308147,0.00018226937,0.00035732862,0.016776891,0.0011346048,0.9526751,0.00008390628,0.011334046,0.00011414191],"about_ca_topic_score_codex":0.000038035567,"about_ca_topic_score_gemma":0.000001324908,"teacher_disagreement_score":0.027825179,"about_ca_system_score_codex":0.000099549856,"about_ca_system_score_gemma":0.00034081205,"threshold_uncertainty_score":0.994383},"labels":[],"label_agreement":null},{"id":"W4295754160","doi":"10.1002/prp2.1003","title":"The signaling and selectivity of α‐adrenoceptor agonists for the human <scp>α2A</scp>, <scp>α2B</scp> and <scp>α2C</scp>‐adrenoceptors and comparison with human α1 and β‐adrenoceptors","year":2022,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Division of Graduate Education; Medical Research Council; Medical Research Council Canada; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Adrenergic receptor; Agonist; Receptor; Pharmacology; Medicine; Internal medicine","score_opus":0.035670028496345305,"score_gpt":0.3604418743473887,"score_spread":0.3247718458510434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295754160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727143,0.024530953,0.00029017893,0.00023171681,0.0001679574,0.0016015504,0.000097091506,0.00003730471,0.00032894604],"genre_scores_gemma":[0.9952181,0.002026455,0.00025949604,0.000070803435,0.0004894903,0.0005537589,0.000046424302,0.00009896091,0.0012365152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951656,0.001167754,0.0004963603,0.0013074451,0.0006601787,0.0012026632],"domain_scores_gemma":[0.9950104,0.0033460248,0.00035620376,0.00036070644,0.00056976086,0.00035690647],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0032968558,0.0005297637,0.0006516481,0.00026203773,0.00520147,0.00027977378,0.00060562487,0.00023692349,0.000049231454],"category_scores_gemma":[0.0007195737,0.00039592822,0.00013238988,0.00043597075,0.0026134471,0.000044644967,0.0010093931,0.0011640424,6.42461e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008104819,0.00027310802,0.012797483,0.0001079626,0.00081588776,0.0000049381633,0.011168322,0.000090868554,0.96306574,0.001005603,0.009874849,0.0007142094],"study_design_scores_gemma":[0.0034340245,0.0047283107,0.0073337904,0.000029255098,0.00029887294,0.00009766472,0.09505651,0.00059902866,0.8550313,0.0012329156,0.03197853,0.00017979719],"about_ca_topic_score_codex":0.00018236498,"about_ca_topic_score_gemma":0.00012480338,"teacher_disagreement_score":0.108034424,"about_ca_system_score_codex":0.00010803736,"about_ca_system_score_gemma":0.00022201259,"threshold_uncertainty_score":0.99984926},"labels":[],"label_agreement":null},{"id":"W4309588157","doi":"10.1002/prp2.1012","title":"Trends of use and factors that determine the choice of oral anticoagulants in women and men with atrial fibrillation","year":2022,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université de Montréal","funders":"Réseau Québécois de Recherche sur les Médicaments; Heart and Stroke Foundation of Canada","keywords":"Atrial fibrillation; Medicine; Internal medicine; Cardiology; Intensive care medicine","score_opus":0.20671104021048722,"score_gpt":0.45717317312819483,"score_spread":0.2504621329177076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309588157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684954,0.00056895794,9.003096e-7,0.0019297588,0.00002630394,0.00042540644,0.0000114204895,0.0000072830862,0.00018043876],"genre_scores_gemma":[0.9989644,0.0003796193,0.000023431407,0.0000091906495,0.00008976703,0.0000039330844,0.000004012293,0.00000842227,0.0005171674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867594,0.0004254321,0.00014712075,0.00019349984,0.00034567236,0.00021234453],"domain_scores_gemma":[0.9987308,0.0009702387,0.00007942413,0.00008554537,0.000082237006,0.000051782874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007491873,0.000080431106,0.00029434366,0.00048078838,0.0001278061,0.000010807269,0.000058678404,0.000022219712,0.00025223792],"category_scores_gemma":[0.00015042444,0.000052751955,0.000035102734,0.0004698324,0.00038687582,0.00013341775,0.00018341004,0.00018426545,1.0662166e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028577675,0.000011234311,0.978373,0.00002647835,0.00021232366,0.0000060157054,0.00946558,0.00006917939,0.007268052,0.00005990477,0.00011978292,0.001530699],"study_design_scores_gemma":[0.0033592551,0.00074444903,0.9799627,0.0000054745665,0.000058129295,0.000004928678,0.012918753,0.0009429675,0.0008447546,0.00003685343,0.0010707959,0.000050932194],"about_ca_topic_score_codex":0.00032837354,"about_ca_topic_score_gemma":0.000028094075,"teacher_disagreement_score":0.006423298,"about_ca_system_score_codex":0.00009218866,"about_ca_system_score_gemma":0.000044182223,"threshold_uncertainty_score":0.27618283},"labels":[],"label_agreement":null},{"id":"W4362657617","doi":"10.1002/prp2.1080","title":"The <scp>N‐Acetylgalactosamine</scp>‐conjugated small interfering <scp>RNA</scp> inclisiran can be coadministered safely with atorvastatin in cynomolgus monkeys resulting in additive low‐density lipoprotein cholesterol reductions","year":2023,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"Medicines Company","keywords":"Atorvastatin; Pharmacology; Lipoprotein; Low-density lipoprotein; Chemistry; Cholesterol; Medicine; Biochemistry","score_opus":0.06344599065991437,"score_gpt":0.36785617125325687,"score_spread":0.3044101805933425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362657617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881655,0.00075301697,0.000019817218,0.004535217,0.0002457643,0.004008715,0.00010801075,0.00023251824,0.0019314676],"genre_scores_gemma":[0.99436355,0.0014190811,0.00014949306,0.00020304706,0.00070825295,0.0014580163,0.00009063314,0.00012354195,0.0014844175],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9918941,0.0025999718,0.00085869513,0.0013792011,0.0011619165,0.0021060721],"domain_scores_gemma":[0.99468225,0.0026866083,0.00024963496,0.0007897026,0.0009766223,0.00061519496],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0053190812,0.0005282102,0.0009811396,0.001292429,0.00096652366,0.00015987309,0.0005546513,0.00029163112,0.000018496108],"category_scores_gemma":[0.004157956,0.0004281523,0.00023824644,0.003111424,0.0013154007,0.00024050202,0.0005764338,0.003434822,0.00004286079],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044814744,0.0041801725,0.045260124,0.0015283521,0.0054378873,0.009855865,0.3580092,0.00068626425,0.49531823,0.00048014708,0.011228059,0.06353424],"study_design_scores_gemma":[0.01810159,0.003690186,0.4286134,0.0011706975,0.0002197739,0.00051246496,0.29976204,0.0019100298,0.24065496,0.0001513225,0.0049177925,0.00029574224],"about_ca_topic_score_codex":0.010962609,"about_ca_topic_score_gemma":0.017264642,"teacher_disagreement_score":0.38335326,"about_ca_system_score_codex":0.0014397441,"about_ca_system_score_gemma":0.0012090979,"threshold_uncertainty_score":0.999817},"labels":[],"label_agreement":null},{"id":"W4386910959","doi":"10.1002/prp2.1137","title":"Impact of amiodarone use on metoprolol concentrations, <scp>α‐OH</scp>‐metoprolol concentrations, metoprolol dosing and heart rate: A cross‐sectional study","year":2023,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"Canadian Institutes of Health Research; Fondation Institut de Cardiologie de Montréal","keywords":"Metoprolol; Amiodarone; Medicine; Antiarrhythmic agent; Bisoprolol; Pharmacokinetics; CYP2D6; Heart rate; Regimen; Pharmacology; Internal medicine; Anesthesia; Atrial fibrillation; Cardiology; Heart failure; Heart disease; Blood pressure; Cytochrome P450","score_opus":0.25031480168469356,"score_gpt":0.5557490032381033,"score_spread":0.3054342015534097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386910959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98918843,0.0032369506,0.000018462302,0.00070617406,0.0011514646,0.0040186234,0.00061691366,0.00027598836,0.000786991],"genre_scores_gemma":[0.99300486,0.0032643676,0.000094239724,0.0004989544,0.00085646886,0.0009605481,0.000085989464,0.00008999163,0.0011445757],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9877465,0.006604018,0.001141262,0.0015408639,0.0010012037,0.0019661898],"domain_scores_gemma":[0.9897318,0.0069879377,0.00035771023,0.00047022334,0.0015845062,0.00086781866],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0078020357,0.00068233407,0.0009827769,0.0013075082,0.0017208796,0.00026787966,0.0006708618,0.00054196466,0.0011131018],"category_scores_gemma":[0.001923873,0.0006345608,0.00037916773,0.0021047154,0.0024522063,0.0006595756,0.00047227138,0.0029835736,0.00025340612],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014114135,0.0029844118,0.45497057,0.000044385983,0.0021344128,0.00012322611,0.007498624,0.0026894738,0.5166083,0.0012311206,0.00983021,0.0004738867],"study_design_scores_gemma":[0.008912156,0.0023376062,0.8672364,0.000011842195,0.00043034882,0.00005885547,0.0037481661,0.0065580914,0.09989417,0.00065868616,0.009799663,0.0003540236],"about_ca_topic_score_codex":0.00029989498,"about_ca_topic_score_gemma":0.000024889061,"teacher_disagreement_score":0.4167141,"about_ca_system_score_codex":0.00047025,"about_ca_system_score_gemma":0.0008963593,"threshold_uncertainty_score":0.9998},"labels":[],"label_agreement":null},{"id":"W4387996961","doi":"10.1002/prp2.1113","title":"Validity, sensitivity and specificity of a measure of medication adherence instrument among patients taking oral anticoagulants","year":2023,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Construct validity; Medicine; Medication adherence; Internal medicine; Psychometrics; Clinical psychology","score_opus":0.282968442205123,"score_gpt":0.47030348901950586,"score_spread":0.18733504681438284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387996961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681526,0.00013512778,0.000055641583,0.0009115852,0.000115840434,0.0006322157,0.000017375236,0.000034522578,0.0012824056],"genre_scores_gemma":[0.9988108,0.0007754197,0.00010625821,0.000023288796,0.000066299996,0.000042436408,0.0000138169435,0.000008772355,0.00015286657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975176,0.0006641756,0.00027888198,0.00035139962,0.0008745171,0.0003134374],"domain_scores_gemma":[0.99807125,0.00040060826,0.00020940271,0.00018518748,0.00095926813,0.00017425533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022047868,0.00010379062,0.0003626538,0.00032021588,0.00010695177,0.0000058134638,0.00011500148,0.00007757126,0.00048518556],"category_scores_gemma":[0.0009433638,0.000093023744,0.000043103504,0.00069053035,0.0011624066,0.00010222315,0.0001532466,0.00038834667,0.000045092376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034275983,0.00062650314,0.85862505,0.00021361948,0.00012321788,0.000021586833,0.0030025425,0.0000012569989,0.12676045,0.00018232009,0.0031428938,0.0069577736],"study_design_scores_gemma":[0.001326364,0.0004517927,0.9488512,0.00016421049,0.000044071294,0.0000049910536,0.0028637003,0.0009895733,0.04501094,0.0001656376,0.000060161292,0.0000673325],"about_ca_topic_score_codex":0.00021487485,"about_ca_topic_score_gemma":0.000019955858,"teacher_disagreement_score":0.09022615,"about_ca_system_score_codex":0.00008072395,"about_ca_system_score_gemma":0.00021250207,"threshold_uncertainty_score":0.53124416},"labels":[],"label_agreement":null},{"id":"W4388671709","doi":"10.1002/prp2.1151","title":"Effects of the <scp>HIV</scp>‐1 maturation inhibitor <scp>GSK3640254</scp> on <scp>QT</scp> interval in healthy participants","year":2023,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"ViiV Healthcare","keywords":"QT interval; Moxifloxacin; Placebo; Medicine; Pharmacokinetics; Pharmacology; Internal medicine; Anesthesia; Antibiotics; Chemistry","score_opus":0.052143180943975485,"score_gpt":0.3958398496353056,"score_spread":0.34369666869133014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388671709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857277,0.005626534,0.000005954119,0.0016008331,0.001124819,0.002780072,0.00020721562,0.00017126658,0.0027555635],"genre_scores_gemma":[0.9860146,0.0019470679,0.000014987819,0.00020149154,0.0002777993,0.0012774437,0.000103750775,0.00006797461,0.010094884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9893204,0.0055704564,0.00066276704,0.001150302,0.00051140157,0.0027846906],"domain_scores_gemma":[0.98452324,0.013903787,0.00022457649,0.0005508417,0.0005211313,0.00027643493],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028377736,0.0004906838,0.00077884505,0.0012431241,0.0008149466,0.00006237182,0.0010000756,0.00049657654,0.00007144796],"category_scores_gemma":[0.007028312,0.000372284,0.00029015413,0.0020532648,0.001856487,0.0002674611,0.0008155243,0.0026792716,0.0042583146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051909056,0.0032362663,0.012757938,0.00035594797,0.001163183,0.00040966205,0.026695998,0.00005919838,0.70238006,0.0007856548,0.25058636,0.0010506116],"study_design_scores_gemma":[0.010139942,0.004240114,0.20437866,0.0002370936,0.00011691089,0.000044178967,0.027333936,0.00012361255,0.7234784,0.0006958357,0.029133456,0.00007789609],"about_ca_topic_score_codex":0.00025429972,"about_ca_topic_score_gemma":0.00022300334,"teacher_disagreement_score":0.2214529,"about_ca_system_score_codex":0.0007201252,"about_ca_system_score_gemma":0.0006981859,"threshold_uncertainty_score":0.9998729},"labels":[],"label_agreement":null},{"id":"W4388982427","doi":"10.1002/prp2.1156","title":"Time to treat the climate and nature crisis as one indivisible global health emergency","year":2023,"lang":"en","type":"editorial","venue":"Pharmacology Research & Perspectives","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Climate change; Maladaptation; Global warming; Natural disaster; Damages; Global health; Deforestation (computer science); Natural resource economics; Environmental planning; Environmental resource management; Business; Political science; Geography; Economic growth; Health care; Medicine; Economics; Ecology; Law; Computer science; Meteorology","score_opus":0.06687538285724298,"score_gpt":0.5046801225219242,"score_spread":0.4378047396646812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388982427","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07431726,0.019081306,7.115143e-7,0.28707638,0.5822215,0.005975354,0.0048211208,0.00048071978,0.02602565],"genre_scores_gemma":[0.006333049,0.21724325,0.00006580152,0.0031379329,0.7587642,0.00125412,0.00040248554,0.00026033673,0.01253882],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933286,0.0011312442,0.0003863238,0.0012289356,0.0017391845,0.0021857428],"domain_scores_gemma":[0.99698675,0.0012885022,0.00014790842,0.0004136764,0.00016153071,0.00100161],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0038934506,0.00039985782,0.00058889075,0.0002302311,0.0014858659,0.000094967436,0.0009103721,0.00071546517,0.019344538],"category_scores_gemma":[0.0012371097,0.00031397486,0.00009712315,0.0015271843,0.0006535753,0.0001833378,0.0019379718,0.0030170823,0.012884662],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030421084,0.0002011663,0.00014610849,0.00012176949,0.00006770916,0.00003071988,0.007081483,0.0000035646922,0.00021547324,0.000016013773,0.9906976,0.0011141668],"study_design_scores_gemma":[0.0009189169,0.0018313247,0.005800578,0.0000801815,0.0000957018,0.0000065880095,0.0070946356,0.000019050536,0.00006346523,0.0015327964,0.9820542,0.00050261244],"about_ca_topic_score_codex":0.0034146614,"about_ca_topic_score_gemma":0.0010821314,"teacher_disagreement_score":0.28393844,"about_ca_system_score_codex":0.002449825,"about_ca_system_score_gemma":0.00037091054,"threshold_uncertainty_score":0.9999312},"labels":[],"label_agreement":null},{"id":"W4392295096","doi":"10.1002/prp2.1180","title":"Effects of vasoactive substances on biomechanics of small resistance arteries of male and female Dahl salt‐sensitive rats","year":2024,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Cardiovascular, Neuropeptides, and Oxidative Stress Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Faculty of Medicine, Memorial University of Newfoundland","keywords":"Vasoactive; Biomechanics; Medicine; Vascular resistance; Internal medicine; Biomedical engineering; Physiology; Blood pressure","score_opus":0.05049884989883409,"score_gpt":0.3893538493083223,"score_spread":0.3388549994094882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392295096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619134,0.03181649,0.00009144948,0.0003771085,0.00014349178,0.0011710494,0.00009756922,0.000027352422,0.004362054],"genre_scores_gemma":[0.98402005,0.014176953,0.0002262347,0.000013459318,0.00012117969,0.00008006762,0.0000049417667,0.00003666107,0.0013204581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965708,0.0011144759,0.00032074985,0.0006819292,0.0008107109,0.0005013379],"domain_scores_gemma":[0.9953891,0.0028134328,0.0000873718,0.00026893534,0.0012684279,0.00017272201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011812242,0.00022069587,0.0007684585,0.00089535647,0.00010652095,0.000018494391,0.0001688301,0.00009917456,0.000091044945],"category_scores_gemma":[0.00048580993,0.00018762721,0.00023712037,0.0010144982,0.0023540717,0.00012583345,0.00017120644,0.00071984954,0.0000066269727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004541873,0.00049140723,0.00023189245,0.0031748195,0.0018971758,0.00077194144,0.010947627,0.0000021953454,0.9726548,0.0027316494,0.0004915394,0.0020630413],"study_design_scores_gemma":[0.0013665217,0.0017821924,0.0072366097,0.0007662643,0.00024088263,0.000036436337,0.008893241,0.000092494054,0.97861594,0.00029991815,0.0005426423,0.0001268671],"about_ca_topic_score_codex":0.0000541607,"about_ca_topic_score_gemma":0.000032787317,"teacher_disagreement_score":0.022106608,"about_ca_system_score_codex":0.00014232846,"about_ca_system_score_gemma":0.00032544654,"threshold_uncertainty_score":0.86736757},"labels":[],"label_agreement":null},{"id":"W4399921412","doi":"10.1002/prp2.1227","title":"Involvement of Piezo 1 mechanoceptors in vascular stiffness in isolated small resistance arteries of male and female Dahl salt‐sensitive hypertensive rats","year":2024,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Salt (chemistry); Internal medicine; Chemistry","score_opus":0.057017810419677566,"score_gpt":0.3586718636268441,"score_spread":0.30165405320716654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399921412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886071,0.008508982,0.00004182952,0.0012595687,0.00021459885,0.0007783257,0.000023610448,0.000023878963,0.0005421261],"genre_scores_gemma":[0.995506,0.0034120507,0.00016611768,0.000107976564,0.00006893723,0.000087645036,0.000013072017,0.000022412094,0.0006157919],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977423,0.0006755881,0.00036049762,0.0005578867,0.00025139065,0.0004123592],"domain_scores_gemma":[0.99845165,0.00057149836,0.00005512847,0.00016087978,0.0006554151,0.00010541384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008304648,0.00017119649,0.000623988,0.0009254644,0.000052435942,0.00000770628,0.000082433035,0.00013709474,0.0003212573],"category_scores_gemma":[0.00019975267,0.00015505393,0.00007606735,0.0009135007,0.00093301357,0.00009175302,0.00011849235,0.0006412493,0.0000081852195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037135044,0.00050588464,0.0021201742,0.00078806916,0.00029604588,0.0005989062,0.024274271,0.000013450547,0.96576864,0.0009024276,0.00060609047,0.00041253146],"study_design_scores_gemma":[0.011591161,0.004773347,0.23797198,0.0022854104,0.0003498676,0.00015259784,0.21177372,0.005081089,0.5205991,0.002365656,0.0023139063,0.0007421467],"about_ca_topic_score_codex":0.00021137676,"about_ca_topic_score_gemma":0.00050316425,"teacher_disagreement_score":0.44516954,"about_ca_system_score_codex":0.00016889189,"about_ca_system_score_gemma":0.00029906866,"threshold_uncertainty_score":0.63229156},"labels":[],"label_agreement":null},{"id":"W4399973654","doi":"10.1002/prp2.1225","title":"Teaching an old drug new tricks: Regulatory insights for the repurposing of hemin in cardiovascular disease","year":2024,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph; Saint John Regional Hospital; Dalhousie University","funders":"Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada","keywords":"Hemin; Medicine; Drug repositioning; Context (archaeology); Biopharmaceutical; Repurposing; Intensive care medicine; Drug; Pharmacology; Disease; Dosing; Drug development; Pharmacy; Adverse effect; Internal medicine; Heme; Biotechnology; Family medicine","score_opus":0.03818132580338167,"score_gpt":0.3854963591912483,"score_spread":0.3473150333878666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399973654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84921217,0.14800681,0.00032838742,0.0009631207,0.00018659228,0.00079409307,0.00001340214,0.000022714554,0.00047273675],"genre_scores_gemma":[0.9942087,0.0019401144,0.00013389786,0.00007153389,0.0010299822,0.00021613472,0.000015873586,0.000039495455,0.0023442972],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99762124,0.0006878592,0.00022928849,0.0006951092,0.00032654204,0.00043997454],"domain_scores_gemma":[0.99885964,0.0002464513,0.000026763548,0.00050073303,0.00014703676,0.00021939019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022268388,0.00016218814,0.00022826665,0.00024356379,0.00019248307,0.000041902087,0.00039305774,0.000092584436,0.000021925784],"category_scores_gemma":[0.0002665664,0.00012727203,0.00029863324,0.00026678533,0.00031951038,0.000020937534,0.0001595869,0.0004838472,0.00000194743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006943084,0.00023233153,0.0002612903,0.00013856085,0.0009560999,0.00006519452,0.007588261,0.0004295136,0.9582333,0.001645714,0.0126528945,0.017102547],"study_design_scores_gemma":[0.0023351018,0.0005071928,0.0022953232,0.000115916875,0.00037340474,0.000018041961,0.01584209,0.005732829,0.64981574,0.002218767,0.32022336,0.0005222476],"about_ca_topic_score_codex":0.00038259482,"about_ca_topic_score_gemma":0.000053860065,"teacher_disagreement_score":0.30841756,"about_ca_system_score_codex":0.00010652024,"about_ca_system_score_gemma":0.000555856,"threshold_uncertainty_score":0.5190003},"labels":[],"label_agreement":null},{"id":"W4401154228","doi":"10.1002/prp2.1254","title":"<scp>FDA</scp> regulatory considerations for oncology drug development","year":2024,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug development; Drug; Regulatory science; Pharmacology; Medicine; Medical physics; Oncology","score_opus":0.5740697868022562,"score_gpt":0.5756126454574475,"score_spread":0.001542858655191326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401154228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5471835,0.08939833,0.0050656153,0.2763314,0.0055488367,0.0070071938,0.000696839,0.0006705856,0.0680977],"genre_scores_gemma":[0.96012896,0.0008239976,0.010078132,0.004909307,0.0021446564,0.0033670792,0.000037680264,0.00010058073,0.01840963],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99428177,0.0012559611,0.0021495696,0.0011217283,0.00017839365,0.0010126058],"domain_scores_gemma":[0.9799563,0.018502362,0.00038681697,0.00032778588,0.00046840805,0.00035831853],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch","insufficient_payload"],"category_scores_codex":[0.032073837,0.0002333737,0.00081515725,0.0011982702,0.00096128526,0.00019531163,0.0003286479,0.00021214617,0.0014318734],"category_scores_gemma":[0.0086132465,0.00029134518,0.00016162262,0.00039273838,0.00059405033,0.000528788,0.00014939344,0.0007422694,0.0033263534],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010601838,0.00020587801,0.00043986045,0.0002729584,0.00035731212,0.00001109094,0.041098315,0.000036915942,0.00026444116,0.2851515,0.6720143,0.00013680257],"study_design_scores_gemma":[0.00091489,0.00015233646,0.0023820593,0.00004138754,0.000015272184,0.000022645188,0.022121614,0.0026742434,0.0007851858,0.08180877,0.88891715,0.00016445498],"about_ca_topic_score_codex":0.00010490948,"about_ca_topic_score_gemma":0.00015012338,"teacher_disagreement_score":0.41294545,"about_ca_system_score_codex":0.0030572638,"about_ca_system_score_gemma":0.0024026989,"threshold_uncertainty_score":0.99995387},"labels":[],"label_agreement":null},{"id":"W4402519017","doi":"10.1002/prp2.70004","title":"Evaluating the quality of multiple‐choice question pilot database: A global educator‐created tool for concept‐based pharmacology learning","year":2024,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Educational Assessment and Pedagogy","field":"Social Sciences","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Western University","funders":"Monash University","keywords":"Context (archaeology); Quality (philosophy); Computer science; Process (computing); Cognition; Medical education; Medicine","score_opus":0.45826043954474494,"score_gpt":0.6897479715448398,"score_spread":0.23148753200009486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402519017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594554,0.0052247006,0.0004990532,0.028265204,0.001780843,0.0021410221,0.00017462396,0.00015517884,0.0023039842],"genre_scores_gemma":[0.9944084,0.00022350825,0.0005560608,0.0001733914,0.0022644335,0.0009214213,0.000075976845,0.000017509597,0.0013592535],"study_design_codex":"bench_or_experimental","study_design_gemma":"qualitative","domain_scores_codex":[0.9895322,0.007939049,0.00037887946,0.0005935896,0.0008420706,0.0007142555],"domain_scores_gemma":[0.97653985,0.021586163,0.00013016598,0.00013101984,0.0014728986,0.00013992035],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012396455,0.00016437753,0.0002564955,0.00018232803,0.0014379009,0.00011181426,0.0005365597,0.00009289422,0.0020358195],"category_scores_gemma":[0.0051229056,0.00013900537,0.0001177419,0.0009666976,0.0018740012,0.00032961098,0.00010660246,0.0007800922,0.000023922206],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035290553,0.002834749,0.09104154,0.0005534135,0.0012416577,0.000008038909,0.07803916,0.0013623815,0.54439294,0.20249337,0.06453449,0.009969204],"study_design_scores_gemma":[0.0141400555,0.008859972,0.12754703,0.00044689068,0.0013651624,0.000010504916,0.41639712,0.07744578,0.034780107,0.015229509,0.30167586,0.0021019906],"about_ca_topic_score_codex":0.0071315565,"about_ca_topic_score_gemma":0.0010334617,"teacher_disagreement_score":0.50961286,"about_ca_system_score_codex":0.0009184098,"about_ca_system_score_gemma":0.004943179,"threshold_uncertainty_score":0.9998621},"labels":[],"label_agreement":null},{"id":"W4403584211","doi":"10.1002/prp2.70028","title":"Higher dose antiviral therapy for herpes infections is associated with a risk of serious adverse events in older adults with chronic kidney disease","year":2024,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Kidney disease; Internal medicine; Cohort; Acute kidney injury; Dialysis; Cohort study; Population","score_opus":0.027546400554790938,"score_gpt":0.3995164358424117,"score_spread":0.37197003528762074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403584211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863187,0.0054295934,0.000013199084,0.0035088847,0.00009417221,0.0036477833,0.00037157018,0.00009318045,0.0005229081],"genre_scores_gemma":[0.99151856,0.0044464837,0.00002742333,0.00011932629,0.00026109762,0.0012608521,0.000037757727,0.000077975405,0.0022505294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968354,0.0005565488,0.00025823616,0.00075540034,0.00071076053,0.0008836401],"domain_scores_gemma":[0.99785125,0.0006314379,0.00006619074,0.0002502869,0.00076710514,0.00043374134],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010107338,0.00026729828,0.00047527335,0.000940882,0.00024306432,0.000018360737,0.00017817398,0.00012955566,0.0015414734],"category_scores_gemma":[0.00020376063,0.00018796872,0.00017007232,0.0015755368,0.0007522128,0.0002643132,0.00007933118,0.0009981908,0.000029902523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13577254,0.023965504,0.6961061,0.0027216824,0.011893587,0.0020240347,0.043301724,0.00008725941,0.025534578,0.0005245061,0.030630512,0.027438007],"study_design_scores_gemma":[0.038842022,0.008318105,0.9257486,0.0017934777,0.00039502053,0.000015877182,0.0020926343,0.0032426836,0.005271696,0.00023219896,0.013579602,0.00046806954],"about_ca_topic_score_codex":0.0008513784,"about_ca_topic_score_gemma":0.00056366035,"teacher_disagreement_score":0.22964256,"about_ca_system_score_codex":0.0008978588,"about_ca_system_score_gemma":0.0024328455,"threshold_uncertainty_score":0.99937123},"labels":[],"label_agreement":null},{"id":"W4404007927","doi":"10.1002/prp2.70024","title":"Identification of cytokine release syndrome and indicators of severity in retrospective databases among patients receiving immunotherapy","year":2024,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Ipsen; Flatiron Health; Pharmacyclics; BeiGene; Janssen Scientific Affairs; Servier; TG Therapeutics; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Retrospective cohort study; Tocilizumab; Lasso (programming language); Database; Internal medicine; Emergency medicine; Computer science; Rheumatoid arthritis","score_opus":0.03275787449147814,"score_gpt":0.40947439796442814,"score_spread":0.37671652347295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404007927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933927,0.003989024,0.000012059368,0.00043765147,0.00010721324,0.0012637915,0.00011169491,0.000038037335,0.00064782414],"genre_scores_gemma":[0.99360937,0.005487781,0.000039225066,0.000008912403,0.000055944914,0.00012107276,0.000023672801,0.00004066983,0.00061332434],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99680585,0.0007403943,0.00050587434,0.0006485328,0.0008377967,0.00046157252],"domain_scores_gemma":[0.9981492,0.00069482066,0.000108257984,0.00032783812,0.00057093456,0.00014891208],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002651147,0.0001665627,0.0004878026,0.0019758337,0.00008972527,0.000022445465,0.00020367793,0.000097674725,0.0014013529],"category_scores_gemma":[0.0006635059,0.00015827807,0.000087361994,0.0020058083,0.0016036967,0.00033027865,0.00019173043,0.0010887685,0.000006519209],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013834682,0.0009098561,0.4782085,0.00038982887,0.00038767868,0.000118002856,0.0067465166,0.0000011707806,0.50658864,0.00019842648,0.00031125412,0.0047566523],"study_design_scores_gemma":[0.0017729,0.000652008,0.88581634,0.00021124768,0.000034686847,0.000020270492,0.002120243,0.0002686622,0.10862464,0.00018915503,0.0001831173,0.00010672625],"about_ca_topic_score_codex":0.0004945482,"about_ca_topic_score_gemma":0.00004359592,"teacher_disagreement_score":0.40760782,"about_ca_system_score_codex":0.00066265184,"about_ca_system_score_gemma":0.00030911824,"threshold_uncertainty_score":0.9995115},"labels":[],"label_agreement":null},{"id":"W4405194679","doi":"10.1002/prp2.70045","title":"Teneurin C‐Terminal Associated Peptide (<scp>TCAP</scp>)‐1 Attenuates Restraint Stress‐Induced Corticosterone Increases in Male Mice and Rats","year":2024,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Stress Responses and Cortisol","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Corticosterone; Terminal (telecommunication); Peptide; Medicine; Internal medicine; Endocrinology; Pharmacology; Biology; Computer science; Hormone; Biochemistry","score_opus":0.0892923553331827,"score_gpt":0.40875734694049476,"score_spread":0.31946499160731207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405194679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923168,0.0038583325,0.0000015637627,0.0013272627,0.00018795702,0.00076424726,0.00014495928,0.00014560517,0.0012532751],"genre_scores_gemma":[0.9925101,0.0041645877,0.000012974478,0.00016563882,0.00021136037,0.00029820425,0.0000049524133,0.000052215764,0.0025799996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940792,0.0023482714,0.0003922415,0.0012717518,0.0006786711,0.0012298638],"domain_scores_gemma":[0.99303544,0.0061407555,0.0000784738,0.00022494094,0.00018229033,0.00033811724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053014286,0.00032297862,0.00038777583,0.0008373506,0.00036078683,0.00032092855,0.000492152,0.00015903979,0.00026190223],"category_scores_gemma":[0.0043263026,0.00030446876,0.00008967126,0.0011235285,0.0009802463,0.00041241248,0.00048037994,0.0013927743,0.00010169052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031924155,0.00064901926,0.010222824,0.0000711265,0.000057183097,0.0054288344,0.0031481169,0.0000087839835,0.97636676,0.00017852525,0.0018518755,0.0016977191],"study_design_scores_gemma":[0.0017408348,0.0013979612,0.25123376,0.00031074474,0.0000724032,0.0007366596,0.013092554,0.0031322702,0.72684294,0.00055006606,0.00059117243,0.00029866784],"about_ca_topic_score_codex":0.000656204,"about_ca_topic_score_gemma":0.00028682998,"teacher_disagreement_score":0.24952383,"about_ca_system_score_codex":0.00034547853,"about_ca_system_score_gemma":0.00034166084,"threshold_uncertainty_score":0.99994075},"labels":[],"label_agreement":null},{"id":"W4405766414","doi":"10.1002/prp2.70047","title":"Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the <scp>FDA</scp> Adverse Event Reporting System","year":2024,"lang":"en","type":"review","venue":"Pharmacology Research & Perspectives","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"U.S. National Library of Medicine; National Institutes of Health; National Center for Complementary and Integrative Health; University of Pittsburgh; Office of Dietary Supplements","keywords":"Cannabis; Adverse Event Reporting System; Drug; Medicine; Adverse effect; Medical prescription; Causality (physics); Psychiatry; Pharmacology","score_opus":0.07679502246363638,"score_gpt":0.44660444580745096,"score_spread":0.36980942334381456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405766414","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16508071,0.82914174,1.7044408e-7,0.0015244015,0.0003836059,0.0029956715,0.00016065591,0.000034600318,0.0006784513],"genre_scores_gemma":[0.11662947,0.8603734,0.000017122442,0.000014665173,0.0003702534,0.0013298785,0.00006088828,0.00009706592,0.021107256],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919248,0.0022572486,0.0023460772,0.0015428026,0.0010761631,0.00085291255],"domain_scores_gemma":[0.995272,0.0005156554,0.0016980623,0.00088235165,0.0012443045,0.0003876651],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009825411,0.00046803418,0.0027617265,0.0039312313,0.00036689083,0.00008506832,0.00022034044,0.00020057858,0.0001028788],"category_scores_gemma":[0.009168319,0.0003253222,0.00083772326,0.006113851,0.0013518851,0.0002506008,0.0010235035,0.0031637147,5.469091e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014493123,0.001511164,0.014200474,0.13972233,0.02031757,0.058567934,0.05038964,0.000011730903,0.001894006,0.00014756528,0.7027436,0.010349042],"study_design_scores_gemma":[0.0016259969,0.0004435336,0.008464693,0.03275355,0.03607108,0.037835717,0.19423294,0.00095446396,0.00037361536,0.00002685291,0.6867066,0.0005109274],"about_ca_topic_score_codex":0.0043950174,"about_ca_topic_score_gemma":0.001912903,"teacher_disagreement_score":0.1438433,"about_ca_system_score_codex":0.0014712337,"about_ca_system_score_gemma":0.003219801,"threshold_uncertainty_score":0.9999199},"labels":[],"label_agreement":null},{"id":"W4405766457","doi":"10.1002/prp2.70046","title":"Part 1: Evaluation of Pediatric Cannabis–Drug Interaction Reports","year":2024,"lang":"en","type":"review","venue":"Pharmacology Research & Perspectives","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Center for Complementary and Integrative Health; U.S. National Library of Medicine; National Institutes of Health; Office of Dietary Supplements","keywords":"Adverse Event Reporting System; Medicine; Cannabis; Drug; Adverse effect; Pharmacoepidemiology; Pharmacology; Psychiatry; Medical prescription","score_opus":0.2367373243542005,"score_gpt":0.5716791758582609,"score_spread":0.3349418515040604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405766457","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011042093,0.98239565,3.2953395e-7,0.0036083083,0.0017449684,0.004572835,0.000057818288,0.000079237514,0.0064366446],"genre_scores_gemma":[0.0011419209,0.9645768,0.000007385433,0.000014575982,0.004219437,0.0029356575,0.000106518164,0.00012847949,0.026869247],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9901803,0.0029974757,0.0011970755,0.0014124525,0.0032222169,0.000990471],"domain_scores_gemma":[0.99353933,0.00015860224,0.00041520316,0.00067833054,0.0047473586,0.000461183],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012025223,0.0005133968,0.0019202643,0.0031376902,0.0002320858,0.00007460749,0.0003224816,0.00037932466,0.0044981674],"category_scores_gemma":[0.0015088377,0.0003959532,0.0009709102,0.0027193,0.0006728875,0.0001662657,0.00043980026,0.0038397333,0.00025633842],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011409154,0.0006139083,0.00001299824,0.019680476,0.001173462,0.00053672557,0.0012178506,0.0000015947544,0.000039794173,0.000053933396,0.81118464,0.16537051],"study_design_scores_gemma":[0.0004684249,0.00034133255,0.000022971664,0.0020448586,0.009020012,0.0007764857,0.0017900242,0.000060030863,0.00006406732,0.00014753059,0.98498625,0.00027800948],"about_ca_topic_score_codex":0.00023546604,"about_ca_topic_score_gemma":0.00003242844,"teacher_disagreement_score":0.1738016,"about_ca_system_score_codex":0.0029057357,"about_ca_system_score_gemma":0.009424997,"threshold_uncertainty_score":0.99984926},"labels":[],"label_agreement":null},{"id":"W4407987271","doi":"10.1002/prp2.70078","title":"In Vitro Signaling Properties of Cannabinoid and Orexin Receptors: How Orexin Receptors Influence Cannabinoid Receptor‐Mediated Signaling","year":2025,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Saskatchewan","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Orexin; Cannabinoid; Receptor; Cannabinoid receptor; Endocannabinoid system; Pharmacology; Orexin receptor; Cannabinoid receptor type 2; Signal transduction; Cannabinoid Receptor Agonists; GPR18; Chemistry; Neuroscience; Biology; Medicine; Internal medicine; Cell biology; Neuropeptide; Agonist","score_opus":0.05675451131578457,"score_gpt":0.3675841950247985,"score_spread":0.3108296837090139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407987271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97866946,0.003631038,0.0000138294245,0.01482621,0.0005574637,0.0016806817,0.0000363251,0.00010425119,0.00048072843],"genre_scores_gemma":[0.9945607,0.0013902879,0.00011669607,0.00031377358,0.00018635964,0.0008024139,0.0000045568245,0.00005634272,0.0025688282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9911118,0.003721143,0.00062968105,0.0015514857,0.0012442819,0.0017415952],"domain_scores_gemma":[0.99621946,0.0016571005,0.00017459218,0.00039309773,0.0011799816,0.0003757979],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0032182748,0.0004601089,0.0007499923,0.0023207266,0.0006768839,0.00019281277,0.0011282748,0.00031187403,0.0004833242],"category_scores_gemma":[0.008152685,0.0004184702,0.00011561973,0.0040919897,0.0035987159,0.0009159898,0.0007433935,0.0021960149,0.00002843078],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002132943,0.00044970837,0.0019416163,0.00028473168,0.00007663571,0.00004546181,0.009822976,0.0001399887,0.97758734,0.0003993224,0.006353773,0.00076552556],"study_design_scores_gemma":[0.0017547886,0.00025973594,0.00018351097,0.00019745468,0.000018755276,0.00000618713,0.011786236,0.0005956194,0.98094314,0.00028853648,0.0036016263,0.000364414],"about_ca_topic_score_codex":0.0012169682,"about_ca_topic_score_gemma":0.0000620787,"teacher_disagreement_score":0.015891269,"about_ca_system_score_codex":0.000840894,"about_ca_system_score_gemma":0.0012369115,"threshold_uncertainty_score":0.9998267},"labels":[],"label_agreement":null},{"id":"W4408739727","doi":"10.1002/prp2.70085","title":"Roadmap and Reflections on Expanding Equity, Diversity, Inclusion, Indigeneity, and Accessibility in Pharmacology Curricula","year":2025,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"University of Toronto","keywords":"Curriculum; Inclusion (mineral); Medical education; Equity (law); Diversity (politics); Curriculum development; Psychology; Pedagogy; Medicine; Sociology; Political science","score_opus":0.3515140080135828,"score_gpt":0.6474004828437994,"score_spread":0.2958864748302166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408739727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90459126,0.002985059,0.00002002161,0.07351346,0.00026446074,0.0014804045,0.000008590439,0.000053580734,0.017083151],"genre_scores_gemma":[0.98629624,0.007991008,0.00005867435,0.0046028728,0.00027418832,0.00013668966,0.0000040780296,0.000011780646,0.00062444643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949494,0.001442503,0.00032463975,0.0008270457,0.00088672695,0.0015697047],"domain_scores_gemma":[0.99511427,0.001841831,0.00004895163,0.0001923573,0.0004937046,0.0023089014],"candidate_categories":["sts","open_science"],"consensus_categories":[],"category_scores_codex":[0.0073297555,0.00020260001,0.0004685106,0.001735396,0.0020562925,0.000041371593,0.00031043382,0.00023933507,0.00044440103],"category_scores_gemma":[0.0080471225,0.00017452851,0.00004919531,0.0012499408,0.001610695,0.00021773776,0.008541482,0.0022971171,0.000010871981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009858214,0.0072185067,0.5198438,0.0017752709,0.0005746331,0.0014208674,0.05880682,0.00000562793,0.19296834,0.0034696,0.13245665,0.07160165],"study_design_scores_gemma":[0.019982044,0.004192229,0.895404,0.0006399803,0.00022578314,0.00011284252,0.017349804,0.0006326764,0.023995543,0.021098383,0.015853085,0.00051363447],"about_ca_topic_score_codex":0.0005781533,"about_ca_topic_score_gemma":0.00020707928,"teacher_disagreement_score":0.37556016,"about_ca_system_score_codex":0.001497006,"about_ca_system_score_gemma":0.0026649002,"threshold_uncertainty_score":0.99947727},"labels":[],"label_agreement":null},{"id":"W4409441308","doi":"10.1002/prp2.70095","title":"Students Perceive Similar Gains in Collaboration, Communication and Professional Skills in Two Distinct Experiential Learning Courses","year":2025,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Problem and Project Based Learning","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Toronto; Government of Canada; Co-operative Education and Work-Integrated Learning Canada","keywords":"Preparedness; Experiential learning; Thematic analysis; Likert scale; Teamwork; Psychology; Medical education; Curriculum; Transformative learning; Critical thinking; Coursework; Capstone course; Qualitative research; Mathematics education; Pedagogy; Medicine; Sociology","score_opus":0.041247565748914757,"score_gpt":0.551353298779562,"score_spread":0.5101057330306472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409441308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777288,0.0020750957,0.000010015264,0.008677072,0.00015602462,0.00087615923,0.000003121365,0.000037247068,0.010436457],"genre_scores_gemma":[0.9947655,0.0015439213,0.00008383475,0.00008938699,0.00008260458,0.00032975496,0.000008338464,0.000008073465,0.0030885627],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99217725,0.006219917,0.00021847324,0.00037907937,0.00050094974,0.0005043046],"domain_scores_gemma":[0.9977852,0.001503899,0.000057309626,0.00009650662,0.0004748797,0.00008219249],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0048322217,0.00010680528,0.000189311,0.00063402404,0.0014201438,0.00013164255,0.00040806393,0.00008366227,0.00037838562],"category_scores_gemma":[0.0015131294,0.00011167405,0.000021118474,0.001361602,0.0011870652,0.00036517336,0.00029708236,0.0010974753,0.0000067980345],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023091443,0.0006673183,0.578722,0.000016274507,0.000032072305,0.000014725338,0.4101614,0.00014690479,0.0022657893,0.005349691,0.0013088958,0.00108402],"study_design_scores_gemma":[0.002938433,0.000093505776,0.31807438,0.00015901912,0.00001214775,4.57586e-7,0.66192204,0.00042236524,0.0003121812,0.00202297,0.013856292,0.00018622595],"about_ca_topic_score_codex":0.0022040613,"about_ca_topic_score_gemma":0.010853125,"teacher_disagreement_score":0.2606476,"about_ca_system_score_codex":0.0005842657,"about_ca_system_score_gemma":0.0010001961,"threshold_uncertainty_score":0.9998799},"labels":[],"label_agreement":null},{"id":"W4412094679","doi":"10.1002/prp2.70147","title":"Aspirin Versus <scp>LMWH</scp> for Thromboprophylaxis Following Hip or Knee Arthroplasty—Clinical Implications and Budget Impact","year":2025,"lang":"en","type":"review","venue":"Pharmacology Research & Perspectives","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Aspirin; Arthroplasty; Randomized controlled trial; Deep vein; Low molecular weight heparin; Population; Clinical trial; Systematic review; Thrombosis; Venous thromboembolism; Surgery; MEDLINE; Physical therapy; Internal medicine","score_opus":0.21974483418892415,"score_gpt":0.5706890048184362,"score_spread":0.35094417062951205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412094679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026735163,0.9808948,0.000048448233,0.0014760433,0.0015177702,0.009817753,0.0002583236,0.00015515357,0.0031581707],"genre_scores_gemma":[0.002176935,0.9866295,0.0004535475,0.00012902904,0.0014182607,0.005174213,0.000154309,0.00012973814,0.0037344585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939673,0.0011495196,0.0010353854,0.0017694246,0.00057023583,0.0015081662],"domain_scores_gemma":[0.9841562,0.013413365,0.00029464922,0.0007711776,0.00069514854,0.0006694838],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00290483,0.0007535566,0.0037529166,0.0012943968,0.00078215933,0.00013840265,0.00044917144,0.00062169286,0.000255351],"category_scores_gemma":[0.0044618594,0.00055738265,0.0016260403,0.0013438019,0.00097066327,0.00016634692,0.0007932315,0.0019562189,0.00009923201],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048052933,0.003583194,0.00023872308,0.01887483,0.016022857,0.0001820857,0.0011009036,8.867932e-7,0.000032804994,0.0019691878,0.22923765,0.7282764],"study_design_scores_gemma":[0.0054356637,0.0075039174,0.0020214566,0.002843449,0.005951991,0.00003340918,0.001882185,0.000009048835,0.00000676868,0.00031598628,0.9737253,0.0002708112],"about_ca_topic_score_codex":0.00007266439,"about_ca_topic_score_gemma":0.000039975977,"teacher_disagreement_score":0.74448764,"about_ca_system_score_codex":0.0009451382,"about_ca_system_score_gemma":0.003036831,"threshold_uncertainty_score":0.9996878},"labels":[],"label_agreement":null},{"id":"W4412120149","doi":"10.1002/prp2.70149","title":"Extending Investigations of <scp>miR</scp>‐126‐5p on the Regulation of <scp>CYP2A6</scp>, the Major Nicotine‐Inactivating Enzyme","year":2025,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research; Fogarty International Center; National Institutes of Health; Canada Research Chairs","keywords":"microRNA; CYP2A6; Nicotine; Messenger RNA; Biology; Enzyme; Chemistry; Internal medicine; Medicine; Genetics; Biochemistry; Gene","score_opus":0.03910911335001511,"score_gpt":0.3721931858446642,"score_spread":0.3330840724946491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412120149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868615,0.0028188375,0.00029223604,0.0026820325,0.0001370978,0.0009924921,0.000034330063,0.000021108513,0.0061603505],"genre_scores_gemma":[0.9968436,0.00018889726,0.00020255746,0.0001567146,0.00026808918,0.00019894849,0.000034909568,0.000028181532,0.0020781108],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99688166,0.0012727892,0.00039695864,0.0005350272,0.00042662665,0.00048696197],"domain_scores_gemma":[0.99593794,0.0023168107,0.00028644645,0.00052595284,0.00084543374,0.00008738467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001755432,0.0002095197,0.00023366809,0.0003125591,0.00055737974,0.000033443896,0.0006113861,0.00017249066,0.00004059632],"category_scores_gemma":[0.0048595965,0.00015541364,0.00015320774,0.00087353867,0.001286391,0.000022184207,0.0003672821,0.0005152582,0.0000074263125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035726815,0.00020304228,0.0015752248,0.00006262706,0.00030944133,5.4916666e-7,0.00126193,0.0004298216,0.9554416,0.014923299,0.025642557,0.000114170034],"study_design_scores_gemma":[0.00053205335,0.0001633485,0.026419276,0.00006430714,0.00007090774,0.0000029342689,0.006105836,0.0008466782,0.95880735,0.0030797198,0.0038699242,0.000037647682],"about_ca_topic_score_codex":0.00004454831,"about_ca_topic_score_gemma":0.000012382219,"teacher_disagreement_score":0.02484405,"about_ca_system_score_codex":0.0001433451,"about_ca_system_score_gemma":0.00040278153,"threshold_uncertainty_score":0.6337584},"labels":[],"label_agreement":null},{"id":"W4412187638","doi":"10.1002/prp2.70121","title":"Pharmacogenomics Education and Knowledge Assessment in Healthcare Curricula: A Scoping Review of the Middle East and North Africa Region","year":2025,"lang":"en","type":"review","venue":"Pharmacology Research & Perspectives","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pharmacogenomics; Curriculum; CINAHL; Medical education; Pharmacy; Health care; MEDLINE; Medicine; Psychology; Family medicine; Political science; Nursing; Psychological intervention; Pedagogy; Pharmacology","score_opus":0.4932962013590145,"score_gpt":0.5932413751997943,"score_spread":0.09994517384077978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412187638","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012090444,0.9856444,0.0000016400952,0.0019490059,0.0015569623,0.0068478594,0.00015576676,0.000028957085,0.002606344],"genre_scores_gemma":[0.0027716404,0.99350446,0.000054145625,0.00053336704,0.00048583263,0.002076359,0.000031246873,0.000059860304,0.00048306797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9869739,0.00907648,0.0012742224,0.00122241,0.00039222484,0.0010607896],"domain_scores_gemma":[0.9956916,0.0018973162,0.0006293241,0.00042780378,0.0008888857,0.0004650913],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0035866657,0.0006918971,0.0021829354,0.00090741506,0.0006202164,0.000035101475,0.000967976,0.0005097234,0.00013560124],"category_scores_gemma":[0.0003556345,0.0005524575,0.00036961676,0.0022689626,0.0014359712,0.00013139278,0.0013717606,0.004424497,0.000008202212],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077093726,0.0018518256,0.0004665886,0.3463971,0.00056400767,0.000027064814,0.0059508896,0.0000021896567,0.000079040554,0.0010650986,0.007977003,0.6355421],"study_design_scores_gemma":[0.0018222118,0.00012637571,0.0001528654,0.20653427,0.002675431,0.00014493709,0.0015837789,0.000093920666,0.00004647963,0.00024521785,0.7857969,0.00077762024],"about_ca_topic_score_codex":0.000048839447,"about_ca_topic_score_gemma":0.000067553636,"teacher_disagreement_score":0.7778199,"about_ca_system_score_codex":0.0006127374,"about_ca_system_score_gemma":0.0075113075,"threshold_uncertainty_score":0.9996927},"labels":[],"label_agreement":null},{"id":"W4413051976","doi":"10.1002/prp2.70164","title":"Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High‐Income Countries","year":2025,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council; National Health and Medical Research Council; University of South Australia","keywords":"Health care; Medicine; Health professionals; Descriptive statistics; Family medicine; Pharmaceutical industry; Conflict of interest; Adverse effect; Pharmaceutical care; Pharmacovigilance; Business; Pharmacology; Pharmacy; Finance","score_opus":0.28827496316396767,"score_gpt":0.6110109335126671,"score_spread":0.32273597034869944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413051976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783653,0.0099134715,0.000015510905,0.005440094,0.0011633746,0.0018848381,0.0027448593,0.00005053739,0.00042198406],"genre_scores_gemma":[0.99678093,0.002126188,0.00007546689,0.00028892703,0.00010637452,0.0001864048,0.00020856703,0.000023795175,0.0002033228],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.990309,0.0061577456,0.0011898755,0.0007204507,0.001011636,0.00061131106],"domain_scores_gemma":[0.99161834,0.0043154606,0.00075165054,0.00048211508,0.0025591028,0.00027334513],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004326322,0.00032680546,0.00090054603,0.00047674368,0.00085551705,0.000010092772,0.0006240641,0.00018057412,0.0014185396],"category_scores_gemma":[0.00052913575,0.00028115464,0.00014359439,0.00095449906,0.0036810709,0.00038194333,0.0003864388,0.0018572682,0.000005168854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005194825,0.0045941058,0.2946951,0.0008770305,0.0028343897,0.000027137621,0.010272224,0.0017043212,0.6548673,0.008020668,0.01565743,0.0012554708],"study_design_scores_gemma":[0.013855748,0.00025589773,0.062458046,0.000623096,0.0033427386,0.000052986208,0.060325686,0.029725913,0.78787214,0.0016102213,0.039289605,0.0005879261],"about_ca_topic_score_codex":0.002872876,"about_ca_topic_score_gemma":0.000447979,"teacher_disagreement_score":0.23223707,"about_ca_system_score_codex":0.00036414832,"about_ca_system_score_gemma":0.0013020706,"threshold_uncertainty_score":0.99996406},"labels":[],"label_agreement":null}]}